Please wait...
| ID | PMID | YEAR | Sequence | MAP | Name | C-ter MOD | N-ter MOD | Linear/Cyclic | Stereo-Chemistry | Modified | Length | Fuction | Activity | RBCs Source | Origin | Experimental structure | Non-Hemolytic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25494332 | 2014 | RFRRLRKKWRKRLKKI{ct:Amid} | T9W | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 50 % Hemolysis at >256 µM | Human | Mutant Peptide | α-Helix | NA | ||
| 25997127 | 2015 | LAANFLPQILCKIARKC{ct:Amid} | B1CTcu5-LIAG | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 30 % Hemolysis at 12.5 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | KIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5K | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 15 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | WIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5W | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 39.11 % Hemolysis at 100 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | RIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5R | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 19.4 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | HIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5H | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 30.4 % Hemolysis at 50 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LIAGLAANFLPQILCKIARKC{ct:Amid} | DB1CTcu5 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 40.22 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25891396 | 2015 | AGYLLGKINLKALAALAKKIL{ct:Amid} | TP10 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 80 % Hemolysis at 512 μg/mL | Human | Deletion Analogue Of The Cpp Transportan | α-Helical-50% TFE solution | NA | ||
| 25891396 | 2015 | AGYLLGKINLKKLAKL({nnr:Aib})KKIL{ct:Amid} | TP10-5 | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid | 21 | Antibacterial, Antibiofilm | 80 % Hemolysis at 512 μg/mL | Human | Transportan 10 Analogues | α-Helical | NA | ||
| 25891396 | 2015 | AGYLLGKINLKPLAKL({nnr:Aib})KKIL{ct:Amid} | TP10-7 | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid | 21 | Antibacterial, Antibiofilm | 59.45 % Hemolysis at 512 μg/mL | Human | Transportan 10 Analogues | α-Helical | NA | ||
| 27351824 | 2016 | LLPIVGNLLKSLL{ct:Amid} | TB | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 20-160 µg/mL | Human | Frog Rana Temporaria Skin | α-Helix | NA | ||
| 27351824 | 2016 | LLPIVGNLLKSLL{ct:Amid} | TB | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 45 % Hemolysis at 320 µg/mL | Human | Frog Rana Temporaria Skin | α-Helix | NA | ||
| 27606830 | 2016 | KGGK{nt:16C- palmitate}{ct:Amid} | C16-KGGK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 5 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KGGK{nt:16C- palmitate}{ct:Amid} | C16-KGGK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 10 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KGGK{nt:16C- palmitate}{ct:Amid} | C16-KGGK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | 20 % Hemolysis at 20 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KGGK{nt:16C- palmitate}{ct:Amid} | C16-KGGK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | >40 % Hemolysis at 50 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KGGK{nt:16C- palmitate}{ct:Amid} | C16-KGGK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <80 % Hemolysis at 100 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KkK{nt:16C- palmitate}{ct:Amid} | C16-KKK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 3 | Antibacterial and Antibiofilm | <20 % Hemolysis at 5 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KkK{nt:16C- palmitate}{ct:Amid} | C16-KKK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 3 | Antibacterial and Antibiofilm | 20 % Hemolysis at 10 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KkK{nt:16C- palmitate}{ct:Amid} | C16-KKK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 3 | Antibacterial and Antibiofilm | >20 % Hemolysis at 20 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KkK{nt:16C- palmitate}{ct:Amid} | C16-KKK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 3 | Antibacterial and Antibiofilm | 40 % Hemolysis at 50 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KkK{nt:16C- palmitate}{ct:Amid} | C16-KKK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 3 | Antibacterial and Antibiofilm | <60 % Hemolysis at 100 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KAaK{nt:16C- palmitate}{ct:Amid} | C16-KAAK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 5 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KAaK{nt:16C- palmitate}{ct:Amid} | C16-KAAK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 10 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KAaK{nt:16C- palmitate}{ct:Amid} | C16-KAAK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 20 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KAaK{nt:16C- palmitate}{ct:Amid} | C16-KAAK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | 20 % Hemolysis at 50 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KAaK{nt:16C- palmitate}{ct:Amid} | C16-KAAK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <40 % Hemolysis at 100 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KLlK{nt:16C- palmitate}{ct:Amid} | C16-KLLK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 5 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KLlK{nt:16C- palmitate}{ct:Amid} | C16-KLLK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <20 % Hemolysis at 10 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KLlK{nt:16C- palmitate}{ct:Amid} | C16-KLLK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | 20 % Hemolysis at 20 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KLlK{nt:16C- palmitate}{ct:Amid} | C16-KLLK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <40 % Hemolysis at 50 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 27606830 | 2016 | KLlK{nt:16C- palmitate}{ct:Amid} | C16-KLLK | Amidation | 16C- palmitate | Linear | L | 16C = palmitate | 4 | Antibacterial and Antibiofilm | <50 % Hemolysis at 100 µg/mL | Sheep | Lipopeptides | NA | NA | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 8 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 15.6 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 31.2 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 62.5 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 125 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 250 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | 0 % Hemolysis at 500 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28533236 | 2017 | {nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C} | CLP-4 | Free | Free | Cyclic | Mix | Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine | 5 | Antibacterial, Antibiofilm | <10 % Hemolysis at 1000 μg/ml | Human | Fusaricidin | NA | Non-hemolytic | ||
| 28559266 | 2017 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antifungal, Antibiofilm | 2.3 - 3.3 % Hemolysis at 32-128 μg/ml | Murine | Variant Of Bovine Hdp Bac2A | NA | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 23 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 64 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 128 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 256 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 512 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P2 | Free | Free | Linear | L | None | 12 | Antibiofilm | 0.84 ± 1.42 % Hemolysis at 1 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P3 | Free | Free | Linear | L | None | 12 | Antibiofilm | 0 % Hemolysis at 2 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P4 | Free | Free | Linear | L | None | 12 | Antibiofilm | 0 % Hemolysis at 4 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P5 | Free | Free | Linear | L | None | 12 | Antibiofilm | 0 % Hemolysis at 8 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P6 | Free | Free | Linear | L | None | 12 | Antibiofilm | <10 % Hemolysis at 16 μg/mL | Human | Brevibacillus Strain | α-Helix | Non-hemolytic | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P7 | Free | Free | Linear | L | None | 12 | Antibiofilm | 10 % Hemolysis at 32 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P8 | Free | Free | Linear | L | None | 12 | Antibiofilm | 9.92 ± 1.04 % Hemolysis at 64 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P9 | Free | Free | Linear | L | None | 12 | Antibiofilm | 16.62 ± 0.85 % Hemolysis at 128 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P10 | Free | Free | Linear | L | None | 12 | Antibiofilm | <40 % Hemolysis at 256 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 37810790 | 2023 | MFLVVKVLKYVV | P11 | Free | Free | Linear | L | None | 12 | Antibiofilm | 72.03 ± 5.61 % Hemolysis at 512 μg/mL | Human | Brevibacillus Strain | α-Helix | NA | ||
| 38276499 | 2024 | AGLGKIGALIQKVIAKYKA | LC-AMP-F1 | Free | Free | Linear | L | None | 21 | Antimicrobial and Antibiofilm | 0 % Hemolysis at 5-160 µM | Rabbit | Wolf Spider Lycosa Coelestis | α-Helical | Non-hemolytic | ||
| 38755634 | 2024 | FLVKLIL{ct:Amid} | BiF | Amidation | Free | Linear | L | None | 7 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 15.63 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 38755634 | 2024 | FLVKLILKILRR{ct:Amid} | BiF2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 1.95 μg/mL | Human | Derivative Of Bif | α-Helical | NA | ||
| 38755634 | 2024 | FLVKLIKKILRR{ct:Amid} | BiF2_7K | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 15.63 μg/mL | Human | Derivative Of Bif | α-Helical | NA | ||
| 38755634 | 2024 | FLVKKIKKILRR{ct:Amid} | BiF2_5K7K | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 10 % Hemolysis at >250 μg/mL | Human | Lysine-Substituted Hybrid Peptide | α-Helical | NA | ||
| 37760693 | 2024 | FLWRISKFLGKKL{ct:Amid} | HRZN-13 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 0.7 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | Non-hemolytic | ||
| 37760693 | 2024 | FLWRISKFLGRKL{ct:Amid} | HRZN-14 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 5.6 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | Non-hemolytic | ||
| 37760693 | 2024 | FLPWISKFLGKIL{ct:Amid} | HRZN-15 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 100 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | FLPWISKFLGKIL{ct:Amid} | HRZN-15 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 8.6 % Hemolysis at 10 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | FLKKIWKLLGKLL{ct:Amid} | HRZN-16 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 100 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | FLKKIWKLLGKLL{ct:Amid} | HRZN-16 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 67 % Hemolysis at 10 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | KLWKLLKKLGRLL{ct:Amid} | HRZN-17 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 18 % Hemolysis at 10 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | KLWKLLKKLGRLL{ct:Amid} | HRZN-17 | Amidation | Free | Linear | L | None | 13 | Antibacterial/ Antibiofilm | 74 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 39 | Antibacterial/ Antibiofilm | 5.4 % Hemolysis at 10 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 37760693 | 2024 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 39 | Antibacterial/ Antibiofilm | 22 % Hemolysis at 100 μg/mL | Human | Sythesized | α-Helical | NA | ||
| 28887200 | 2018 | FLFTVA-{nnr:Dhb}{ct:Acet} | ASP-1 | Acetylation | Free | Linear | L | Dhb = dehydrobutyrine | 7 | Antibacterial, Anti-MRSA, Antibiofilm | ~6 % Hemolysis at 128 μg/ml | Human | Bacillus Subtilis Urid 12.1 | β-Sheet | Low hemolytic | ||
| 29407961 | 2018 | {nnr:dab}{nnr:Dab}{nnr:Dab}L{nnr:dab}{nnr:Dab}{nnr:Dab}L{nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nt:R6 = 4-methyl-hexanoyl}{ct:Amid} | Lipopeptide-13 | Amidation | R6 = 4-methyl-hexanoyl | Linear | Mix | Dab = 2,4-diaminobutanoic acid, dab = D-2,4-diaminobutanoic acid, f = D-phenylalanine | 24 | Antifungal, Antibiofilm | 21 % Hemolysis at 1 mM | Mouse | Linear Battacin Analogue | NA | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 0 % Hemolysis at 1 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | Non-hemolytic | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 0 % Hemolysis at 5 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | Non-hemolytic | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 5.1 % Hemolysis at 10 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 16.8 % Hemolysis at 20 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 36.1 % Hemolysis at 40 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 47.9 % Hemolysis at 60 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30004427 | 2018 | FLFSLIRKAIGGLISAFK | A3 | Free | Free | Linear | L | None | 18 | Antimicrobial and Antibiofilm activities | 49.4 % Hemolysis at 80 μM | Human | North African Scorpion Androctonus Amoeruxi, | α-Helix | NA | ||
| 30216370 | 2018 | ILKPGGGTSGGLLGGLLGKVTSVIPGLNNI | α4 | Free | Free | Linear | L | None | 30 | Antibiofilm | 0 % Hemolysis at 100 μM | Human | Human Splunc1 (Short Palate Lung And Nasal Epithelial Clone 1) | Helical amphipathic structure | Non-hemolytic | ||
| 30216370 | 2018 | ILKKWWGTSGGLLGGLLGKVTSVIKGLNNI | α4M1 | Free | Free | Linear | L | None | 30 | Antibiofilm | 0 % Hemolysis at 100 μM | Human | Human Splunc1 (Short Palate Lung And Nasal Epithelial Clone 1) | Helical amphipathic structure | Non-hemolytic | ||
| 30283025 | 2018 | KKKKKKAAFAAWAAFAA{ct:Amid} | 6K-F17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm | 0 % Hemolysis at >500 μg/ml | Human | Synthetic Amps | NA | Non-hemolytic | ||
| 30301180 | 2018 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 0 % Hemolysis at 64 µM | Mouse | African Clawed Fogs Xenopus Laevis | 50% TFE and 30mM SDS = α-Helical, 10 mM sodium phosphate buffer = Random coil | Non-hemolytic | ||
| 30322120 | 2018 | FLGAVLKVAGKLVPAAICKISKKC | Brevinin-1GHa | Free | Free | Linear | L | None | 24 | Antibiofilm, Antibacterial, Antifungal | 20 % Hemolysis at 16 µM | Horse | Frog Hylarana Guentheri | α-Helix | NA | ||
| 29959905 | 2019 | KRFIKWYNAWNEKRRVY{ct:Amid} | CXCL14-C17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <10 % Hemolysis at 1024 µM | Human | Human Chemokine Cxcl14 | α-Helix | NA | ||
| 29959905 | 2019 | KRFIKWYKAWNKKRRVY{ct:Amid} | CXCL14-C17-a1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <10 % Hemolysis at 1024 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | NA | ||
| 29959905 | 2019 | KRFIKWYKAWNKKWRKY{ct:Amid} | CXCL14-C17-a2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | 10 % Hemolysis at 480 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | NA | ||
| 29959905 | 2019 | KRFKKWYKAWRKKWRKY{ct:Amid} | CXCL14-C17-a3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | 10 % Hemolysis at 700 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | NA | ||
| 29959905 | 2019 | KRFIKWYNAWNEKRRVY{ct:Amid} | CXCL14-C17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <5 % Hemolysis at 256 µM | Human | Human Chemokine Cxcl14 | α-Helix | Non-hemolytic | ||
| 29959905 | 2019 | KRFIKWYKAWNKKRRVY{ct:Amid} | CXCL14-C17-a1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <5 % Hemolysis at 256 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | Non-hemolytic | ||
| 29959905 | 2019 | KRFIKWYKAWNKKWRKY{ct:Amid} | CXCL14-C17-a2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <5 % Hemolysis at 256 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | Non-hemolytic | ||
| 29959905 | 2019 | KRFKKWYKAWRKKWRKY{ct:Amid} | CXCL14-C17-a3 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm, Anti-inflammatory | <5 % Hemolysis at 256 µM | Human | Analog Of Cxcl14-C17 With Substitutions | α-Helix | Non-hemolytic | ||
| 30500360 | 2019 | PFKLSLHL{ct:Amid} | Jelleine-I | Amidation | Free | Linear | L | None | 8 | Antibiofilm, Antimicrobial | ~5 % Hemolysis at 256 µM | Mouse | Royal Jelly Of Honeybees (Apis Mellifera) | NA | Low hemolytic | ||
| 30500360 | 2019 | P{nnr:Fc}KLSLHL{ct:Amid} | fluorine-Jelleine-I (F-J-I) | Amidation | Free | Linear | L | Fc = 4-F-phe-amino acid | 8 | Antibiofilm, Antimicrobial | 3 % Hemolysis at 256 µM | Mouse | Jelleine-I Halogenated Derivatives | NA | Low hemolytic | ||
| 30500360 | 2019 | P{nnr:Fd}KLSLHL{ct:Amid} | chlorine-Jelleine-I (Cl-J-I) | Amidation | Free | Linear | L | Fd = 4-Cl-phe-amino acid | 8 | Antibiofilm, Antimicrobial | 2 % Hemolysis at 256 µM | Mouse | Jelleine-I Halogenated Derivatives | NA | Low hemolytic | ||
| 30500360 | 2019 | P{nnr:Fe}KLSLHL{ct:Amid} | bromine-Jelleine-I (Br-J-I) | Amidation | Free | Linear | L | Fe = 4-Br-phe-amino acid | 8 | Antibiofilm, Antimicrobial | ~4 % Hemolysis at 256 µM | Mouse | Jelleine-I Halogenated Derivatives | NA | Low hemolytic | ||
| 30500360 | 2019 | P{nnr:Ff}KLSLHL{ct:Amid} | iodine-Jelleine-I (I-J-I) | Amidation | Free | Linear | L | Ff = 4-I-phe-amino acid | 8 | Antibiofilm, Antimicrobial | ~10 % Hemolysis at 256 µM | Mouse | Jelleine-I Halogenated Derivatives | NA | Low hemolytic | ||
| 30508627 | 2019 | GWGSFFKKAAHVGKHVGKAALTHYL | Pleurocidin | Free | Free | Linear | L | None | 25 | Antibiofilm, Antibacterial | 10 % Hemolysis at 32 µM | Mouse | Fish Winter Flounder (Pseudopleuronectes Americanus) | 10 mM sodium phosphate buffer = Random coil, SDS and TFE = α-Helix | NA | ||
| 30521892 | 2019 | RYAKMKRRRRRVARRHRRR | PEP-NKSM | Free | Free | Linear | L | None | 19 | biofilm Anti-adherent activity, Antibiofilm | 12 % Hemolysis at 256 µM | Human | Derived From Human Virus Proteomes | α-Helix | Low hemolytic | ||
| 31118709 | 2019 | KFKKLFKKLSPVFKRIVQRIKDFLR{nt:Amid} | B1 | Free | Amidation | Linear | L | None | 25 | Antibiofilm, Antibacterial | 37 % Hemolysis at 150 µM | Human | Hybrid Peptide From Ll-37 And Bmap-27 | α-Helix = 88% and Random coils = 12% | NA | ||
| 30753486 | 2019 | VNWKKILGKIIKVVK{ct:Amid} | LL-III | Amidation | Free | Linear | L | None | 15 | Antibiofilm, Antifungal | 50 % Hemolysis at 157 µM | Human | Lasioglossum Laticeps Bee Venoms | 30% TFE = α-Helix | NA | ||
| 30753486 | 2019 | VNWKKILGK{d}IIKVVK{ct:Amid} | LL-III/43 | Amidation | Free | Linear | Mix | None | 15 | Antibiofilm, Antifungal | 50 % Hemolysis at 400 µM | Human | Derived From Ll-Iii But With D-Leu | 30% TFE = α-Helix | NA | ||
| 30753486 | 2019 | GKWMSLLKHILK{ct:Amid} | HAL-2 | Amidation | Free | Linear | L | None | 12 | Antibiofilm, Antifungal | 50 % Hemolysis at 78 µM | Human | Halictus Sexcinctus Bee Venom | 30% TFE = α-Helix | NA | ||
| 30753486 | 2019 | GKWMKLLKKILK{ct:Amid} | peptide I | Amidation | Free | Linear | L | None | 12 | Antibiofilm, Antifungal | 50 % Hemolysis at 339 µM | Human | Analogs Of Hal-2 | 30% TFE = α-Helix | NA | ||
| 30753486 | 2019 | GKWMKLL{d}KKILK{ct:Amid} | peptide VIII | Amidation | Free | Linear | Mix | None | 12 | Antibiofilm, Antifungal | 50 % Hemolysis at 400 µM | Human | Modified Hal-2 | 30% TFE = α-Helix | NA | ||
| 30802593 | 2019 | MFTLKKPLLLLFFLGTINLSLCEEERNADEEERRDDPEERDVEVEKRFIVPSIFLLKKAFCIALKKC | Japonicin-2LF | Free | Free | Linear | L | None | 67 | Antibiofilm, Antimicrobial | > 80 % Hemolysis at 64 µM | Horse | Limnonectes Fujianensis (Fujian Large-Headed Frog) | aqueous = Random coil, membrane-mimic solutions = α-Helix | NA | ||
| 30951211 | 2019 | {nnr:Nlys}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Nile}{nt:H}{ct:Amid} | GN-2 | Amidation | H | Linear | L | Nlys = Nlys, Ntrp = Ntrp, Nile = Nile | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Peptoids Of Gn-2 | NA | Low hemolytic | ||
| 30951211 | 2019 | {nnr:Nlys}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Nile}{nt:H}{ct:Amid} | GN-2-Nlys1-4Ntrp5-8 | Amidation | H | Linear | L | Nlys = Nlys, Ntrp = Ntrp, Nile = Nile | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Peptoids Of Gn-2 | NA | Low hemolytic | ||
| 30951211 | 2019 | {nnr:Nlys}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Npm}{nt:H}{ct:Amid} | GN-2-Npm9 | Amidation | H | Linear | L | Nlys = Nlys, Ntrp = Ntrp, Npm = Npm | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Peptoids Of Gn-2 | NA | NA | ||
| 30951211 | 2019 | RWKRWWRWI{ct:Amid} | GN-2 | Amidation | Free | Linear | L | None | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Peptide | water = α-Helix, TFE = α-Helix | NA | ||
| 30951211 | 2019 | RWRRWWRWI{ct:Amid} | GN-2-Arg1,3,4,7 | Amidation | Free | Linear | L | None | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Analogue Peptide | water = Random coil, TFE = Random coil | Low hemolytic | ||
| 30951211 | 2019 | KWKKWWKWI{ct:Amid} | GN-2-Lys1,3,4,7 | Amidation | Free | Linear | L | None | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Analogue Peptide | water = Random coil, TFE = Random coil | Low hemolytic | ||
| 30951211 | 2019 | KKKKWWWWI{ct:Amid} | GN-2-Lys1-4Trp5-8 | Amidation | Free | Linear | L | None | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Analogue Peptide | NA | Low hemolytic | ||
| 30951211 | 2019 | KWKKWWKWF{ct:Amid} | GN-2-Lys1,3,4,7Phe9 | Amidation | Free | Linear | L | None | 9 | Antibiofilm, Antibacterial | <10 % Hemolysis at 128 μg/mL | Human | Synthetic Analogue Peptide | water = Random coil, TFE = Random coil | NA | ||
| 31199859 | 2019 | FIGAIARLLSKIF | BmKn-2 | Free | Free | Linear | L | None | 13 | Antimicrobial, Anticancer, Antibiofilm | 100 % Hemolysis at 800 μM | Sheep | Scorpion Mesobuthus Martensii Karsch | α-Helix | NA | ||
| 31199859 | 2019 | FIGAIARLLSKI | BmKn-21 | Free | Free | Linear | L | None | 12 | Antibiofilm, Antibacterial | 100 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | NA | ||
| 31199859 | 2019 | FIGAIARLLSK | BmKn-22 | Free | Free | Linear | L | None | 11 | Antibiofilm, Antibacterial | 10 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | Low hemolytic | ||
| 31199859 | 2019 | FIGAIARLLS | BmKn-23 | Free | Free | Linear | L | None | 10 | Antibiofilm, Antibacterial | 5 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | Non-hemolytic | ||
| 31199859 | 2019 | FIGAIARLL | BmKn-24 | Free | Free | Linear | L | None | 9 | Antibiofilm, Antibacterial | 0 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | Non-hemolytic | ||
| 31199859 | 2019 | FIGAIARL | BmKn-25 | Free | Free | Linear | L | None | 8 | Antibiofilm, Antibacterial | 10 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | Low hemolytic | ||
| 31199859 | 2019 | FIGAIAR | BmKn-26 | Free | Free | Linear | L | None | 7 | Antibiofilm, Antibacterial | 0 % Hemolysis at 800 μM | Sheep | Bmkn–2 Truncated Derivatives | NA | Non-hemolytic | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT{ct:OH} | Ranatuerin-2Pb | OH | Free | Linear | L | None | 34 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 16.11 μM | Horse | Frog Rana Pipiens | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC{ct:OH} | RPa | OH | Free | Linear | L | None | 32 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 63.9 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAAL{ct:Amid} | RPb | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 178 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT{ct:OH} | Ranatuerin-2Pb | OH | Free | Linear | L | None | 34 | Antimicrobial, Antibiofilm | 20 % Hemolysis at 8 μM | Horse | Frog Rana Pipiens | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC{ct:OH} | RPa | OH | Free | Linear | L | None | 32 | Antimicrobial, Antibiofilm | 20 % Hemolysis at 32 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAAL{ct:Amid} | RPb | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 20 % Hemolysis at 64 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31016969 | 2019 | KKLRLKIAFK | PaDBS1R6F10 | Free | Free | Linear | L | None | 10 | Antibiofilm, Antibacterial, Anti-infective | 50 % Hemolysis at >100 μM | Human | Derived From A Pyrobaculum Aerophilum Ribosomal Protein | NA | Low hemolytic | ||
| 31363941 | 2019 | KWKKLLKKPLLKKLLKKL{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilms | 14 % Hemolysis at 100 μM | mouse | Cecropin A-Magainin 2 Hybrid Analog Peptide | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | NA | ||
| 31363941 | 2019 | KWKKLLKKPLLKKLLK{ct:Amid} | P5-CT1 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | Non-hemolytic | ||
| 31363941 | 2019 | KWKKLLKKPLLKKL{ct:Amid} | P5-CT2 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = Random coil, LTA and LPS = Random coil | Non-hemolytic | ||
| 31363941 | 2019 | KKLLKKPLLKKLLKKL{ct:Amid} | P5-NT1 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | Non-hemolytic | ||
| 31363941 | 2019 | LLKKPLLKKLLKKL{ct:Amid} | P5-NT2 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | Non-hemolytic | ||
| 31363941 | 2019 | KKPLLKKLLKKL{ct:Amid} | P5-NT3 | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antibiofilms | 0 % Hemolysis at 100 μM | mouse | Truncated Peptides P5 | 10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix | Non-hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 4.30 ± 0.15 % Hemolysis at 31.25 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 4.82 ± 0.33 % Hemolysis at 62.5 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 6.58 ± 0.25 % Hemolysis at 125 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | NA | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 10.01 ± 0.52 % Hemolysis at 250 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | NA | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 14.46 ± 1.82 % Hemolysis at 500 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | NA | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 1.26 ± 0.38 % Hemolysis at 31.25 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 3.12 ± 0.38 % Hemolysis at 62.5 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 2.32 ± 0.43 % Hemolysis at 125 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 4.82 ± 0.74 % Hemolysis at 250 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 9.27 ± 0.27 % Hemolysis at 500 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | NA | ||
| 31426323 | 2019 | ALWKTLLKHVGKAAGKAALNAVTDMVNQ{ct:Amid} | Der-PS4 | Amidation | Free | Linear | L | None | 28 | Antimicrobial, Antibiofilm, Antiproliferative, Anticancer | 50 % Hemolysis at 128 μM | Horse | Waxy Monkey Tree Frog, Phyllomedusa Sauvagii | mimetic environment(DOPE, DOPC and DOPG, TFE) = α-Helix | NA | ||
| 31319057 | 2019 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL-37 | Free | Free | Linear | L | None | 37 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 170 μM | Human | Human Innate Immune Peptide Ll-37 | α-Helix | NA | ||
| 31319057 | 2019 | GFKRIVQRIKDFLRNLV{ct:Amid} | GF-17 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 180 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17tF-W | Amidation | Free | Linear | Mix | X1 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 12.1 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17mF-W | Amidation | Free | Linear | Mix | X1 = 4-methylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 7.1 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | Low hemolytic | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17W2 | Amidation | Free | Linear | Mix | X1 = 4-methylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 8 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | Low hemolytic | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17tF2 | Amidation | Free | Linear | Mix | X1 = 4-t-butylphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 32.5 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17B-tF | Amidation | Free | Linear | Mix | X1 = biphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 30.2 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KD {nnr:X2}L{d}RKLV{ct:Amid} | 17BIPHE2 | Amidation | Free | Linear | Mix | X1 = biphenylalanine, X2 = biphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 61.5 % Hemolysis at 220 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17tF-W | Amidation | Free | Linear | Mix | X1 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17mF-W | Amidation | Free | Linear | Mix | X1 = 4-methylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17W2 | Amidation | Free | Linear | Mix | X1 = 4-methylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17tF2 | Amidation | Free | Linear | Mix | X1 = 4-t-butylphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid} | 17B-tF | Amidation | Free | Linear | Mix | X1 = biphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at > 440 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31319057 | 2019 | G{nnr:X1}KRL{d}VQRL{d}KD {nnr:X2}L{d}RKLV{ct:Amid} | 17BIPHE2 | Amidation | Free | Linear | Mix | X1 = biphenylalanine, X2 = biphenylalanine, l = D amino acid | 17 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 180 μM | Human | Synthetic Ll-37 Derived Peptides | NA | NA | ||
| 31448597 | 2019 | KWKLFKKIGAVLKVL{ct:Amid} | CM15 | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 40 ± 5 % Hemolysis at 2 μM | mouse | Derived From Citropin1.1 | α-Helix | NA | ||
| 31448597 | 2019 | GGHKWKLFKKIGAVLKVL{ct:Amid} | GGH-CM15 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 29 ± 2 % Hemolysis at 2 μM | mouse | Variant Of Cm15 | α-Helix | NA | ||
| 31448597 | 2019 | VIHKWKLFKKIGAVLKVL{ct:Amid} | VIH-CM15 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 29 ± 3 % Hemolysis at 1 μM | mouse | Variant Of Cm15 | α-Helix | NA | ||
| 31448597 | 2019 | GLFDVIKKVASVIGGL{ct:Amid} | citropin1.1 | Amidation | Free | Linear | L | None | 16 | Antibacterial, Antibiofilm | 16.5 ± 3 % Hemolysis at 10 μM | mouse | Tree Frog Of The Litora Genus | α-Helix | NA | ||
| 31448597 | 2019 | GGHGLFDVIKKVASVIGGL{ct:Amid} | GGH-citropin1.1 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm | 0.2 ± 0.05 % Hemolysis at 34 μM | mouse | Modified Citropin1.1 | α-Helix | Non-hemolytic | ||
| 31448597 | 2019 | VIHGLFDVIKKVASVIGGL{ct:Amid} | VIH-citropin1.1 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm | 0.9 ± 0.1 % Hemolysis at >33 μM | mouse | Modified Citropin1.1 | α-Helix | Non-hemolytic | ||
| 31207076 | 2019 | LRWWLWKLLRRMR{ct:Amid} | LR-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm, | 0 % Hemolysis at 3.3 μM(PBS) | Rabbit | Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,) | NA | Non-hemolytic | ||
| 31207076 | 2019 | LRWWLWKLLRRMR{ct:Amid} | LR-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm, | 0 % Hemolysis at 3.3 μM(IGF) | Rabbit | Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,) | NA | Non-hemolytic | ||
| 31207076 | 2019 | LRWWLWKLLRRMR{ct:Amid} | LR-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm, | >80 % Hemolysis at 52.3 μM(PBS) | Rabbit | Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,) | NA | NA | ||
| 31207076 | 2019 | LRWWLWKLLRRMR{ct:Amid} | LR-10 | Amidation | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm, | 100 % Hemolysis at 52.3 μM(IGF) | Rabbit | Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,) | NA | NA | ||
| 31635388 | 2019 | GLWSKIKDAA-KTAGKAALGFVNEMV | DPT9 | Free | Free | Linear | L | None | 25 | Antimicrobial, Antibiofilm, Anticancer | 50 % Hemolysis at 210 μM | Horse | Derived From Frog Phyllomedusa Tarsius Dpt9 | NA | NA | ||
| 31635388 | 2019 | GLWSKIKKAA-KTAGKAALGFVNKMV | K8, 23-DPT9 | Free | Free | Linear | L | None | 25 | Antimicrobial, Antibiofilm, Anticancer | 50 % Hemolysis at 107 μM | Horse | Analogue And Modified Dtp9 | NA | Low hemolytic | ||
| 31752079 | 2019 | FLQHIIGALGHLF | GHa | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 20 µM | Human | Frog Hylarana Guentheri | α-Helix | NA | ||
| 31752079 | 2019 | FLQKIIGALGKLF | GHaK | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 16 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQKIIGALGHLF | GHa4K | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 26 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQHIIGALGKLF | GHa11K | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 15 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQHIIGALGHLF | GHa | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 115 µM | Human | Frog Hylarana Guentheri | α-Helix | NA | ||
| 31752079 | 2019 | FLQKIIGALGKLF | GHaK | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 66 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQKIIGALGHLF | GHa4K | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 69 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31752079 | 2019 | FLQHIIGALGKLF | GHa11K | Free | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 40 µM | Human | Gha Analogues | α-Helix | NA | ||
| 31520928 | 2019 | YIRKIRRFFKKLKKILKK{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 10 % Hemolysis at 640 µg/ml | Murine | H5-Derived Peptides | Helical | Low hemolytic | ||
| 31520928 | 2019 | SYERKINRHFKTLKKNLKKK{ct:Amid} | P9 | Amidation | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKLKKILKK{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | Helical | Low hemolytic | ||
| 31520928 | 2019 | SYERKINRHFKTLKKNLKKK{ct:Amid} | P9 | Amidation | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.13 % Hemolysis at 25 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.23 % Hemolysis at 50 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.38 % Hemolysis at 75 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.75 % Hemolysis at 100 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.83 % Hemolysis at 150 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 1.6 % Hemolysis at 200 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}{conj:C8}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C8 | Amidation | Free | Linear | Mix | C8 = C8 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}{conj:C10}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C10 | Amidation | Free | Linear | Mix | C10 = C10 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}{conj:C12}RIK{d}TLL{ct:Amid} | Ano-D4,7-4C12 | Amidation | Free | Linear | Mix | C12 = C12 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 32 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C8}TLL{ct:Amid} | Ano-D4,7-7C8 | Amidation | Free | Linear | Mix | C8 = C8 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 256 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C10}TLL{ct:Amid} | Ano-D4,7-7C10 | Amidation | Free | Linear | Mix | C10 = C10 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 128 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | Low hemolytic | ||
| 31676352 | 2019 | GLLK{d}RIK{d}{conj:C12}TLL{ct:Amid} | Ano-D4,7-7C12 | Amidation | Free | Linear | Mix | C12 = C12 | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 32 µM | mouse | Synthestic Amps With Conjugate Fatty Acid | 10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica | NA | ||
| 31676352 | 2019 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 µM | mouse | Venom Sac Of Solitary Spider Wasps | α-Helical | Low hemolytic | ||
| 31676352 | 2019 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 75 % Hemolysis at 2 µM | mouse | Honey Bee Apis Mellifera | α-Helical | NA | ||
| 31887002 | 2020 | LKKLACRLKKLACRLKKLACR{ct:Amid} | ACR3 | Amidation | Free | Linear | L | None | 21 | Antibiofilm, Antifungal, Antibacterial | 10 % Hemolysis at >128 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical | Low hemolytic | ||
| 31778756 | 2020 | RIVQRIKKWLLKWKKLGY | peptide 5 | Free | Free | Linear | L | None | 18 | Antibiofilm, Antibacterial | <10 % Hemolysis at 1024 μg/ml | mouse | Synthetic Peptide | SDS = α-Helix | Low hemolytic | ||
| 31778756 | 2020 | GLLRKWGKKWKEFLRRVWK | peptide 6.2 | Free | Free | Linear | L | None | 19 | Antibiofilm, Antibacterial | <5 % Hemolysis at 128 μg/ml | mouse | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 31778756 | 2020 | GLLRKWGKKWKEFLRRVWK | peptide 6.2 | Free | Free | Linear | L | None | 19 | Antibiofilm, Antibacterial | 30 % Hemolysis at 1024 μg/ml | mouse | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 32619153 | 2020 | ITRYLDKILRILRKYLKA | Pep-IA18 | Free | Free | Linear | L | None | 18 | Antifungal, Antibiofilm | 1 % Hemolysis at 450 μM | Human | Designed From Profilin, A Protein From Insect (Fall Armyworm)Spodoptera Frugiperda | water = Random coil, 50% TFE/water (v/v) and SDS micelle = α-Helix | Non-hemolytic | ||
| 32619153 | 2020 | ITRYLDKILRILRKYLKA | Pep-IA18 | Free | Free | Linear | L | None | 18 | Antifungal, Antibiofilm | | Human | Designed From Profilin, A Protein From Insect (Fall Armyworm)Spodoptera Frugiperda | water = Random coil, 50% TFE/water (v/v) and SDS micelle = α-Helix | Non-hemolytic | | ||
| 32397600 | 2020 | SLWGKLKEMAAAAGKAALNAVNGLVNQ{ct:Amid} | DRP-AC4 | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 26.25 μM | Horse | Frog Skin Agalychnis Callidryas(Dermaseptin) | aqueous = Random coil,50%(TFE) = α-Helix | NA | ||
| 32397600 | 2020 | SLWGKLKEMLAKAGKAVANAVNGLANQ{ct:Amid} | DRP-AC4a | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 14.49 μM | Horse | Analogue Of Drp-Ac4 | aqueous = Random coil,50%(TFE) = α-Helix | NA | ||
| 32397600 | 2020 | SLWGKLKEMLAAAGKAVANAVNGLANQ{ct:Amid} | DRP-AC4b | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 21.53 μM | Horse | Analogue Of Drp-Ac4 | aqueous = Random coil,50%(TFE) = α-Helix | NA | ||
| 32347293 | 2020 | FLGALFKVASKLVPAAICSISKKC | Brevinin-1GHd | Free | Free | Linear | L | None | 24 | Antimicrobial, Anticancer, Antibiotic, Antibiofilm | 13 % Hemolysis at 32 μM | Horse | Frog Skin, Hylarana Guenther | aqueous(10 mM NH4AC buffer) = Random coil, membrane-mimetic environment (50% TFE in 10 mM NH4AC)membrane-mimetic environment (50% TFE in 10 mM NH4AC) = α-Helix | NA | ||
| 32334835 | 2020 | QAK{nt:Amid} | QAK | Free | Amidation | Linear | L | None | 3 | Antibacterial, Antibiofilm | 12 % Hemolysis at 30 µg/ml | Rabbit | Hemolymph Non-Mulberry Silkworm Antheraea Mylitta | NA | NA | ||
| 32334835 | 2020 | QAK{nt:Amid} | QAK | Free | Amidation | Linear | L | None | 3 | Antibacterial, Antibiofilm | 18 % Hemolysis at 60 µg/ml | Rabbit | Hemolymph Non-Mulberry Silkworm Antheraea Mylitta | NA | NA | ||
| 32334835 | 2020 | QAK{nt:Acet}{ct:Acet} | acetylated-QAK | Acetylation | Acetylation | Linear | L | None | 3 | Antibacterial, Antibiofilm | 1 % Hemolysis at 3.75 µg/ml | Rabbit | Synthesized-Qak | NA | Low hemolytic | ||
| 32334835 | 2020 | QAK{nt:Acet}{ct:Acet} | acetylated-QAK | Acetylation | Acetylation | Linear | L | None | 3 | Antibacterial, Antibiofilm | 2 % Hemolysis at 7.5 µg/ml | Rabbit | Synthesized-Qak | NA | Low hemolytic | ||
| 32334835 | 2020 | QAK{nt:Acet}{ct:Acet} | acetylated-QAK | Acetylation | Acetylation | Linear | L | None | 3 | Antibacterial, Antibiofilm | 19.55 % Hemolysis at 100 µg/ml | Rabbit | Synthesized-Qak | NA | Low hemolytic | ||
| 32334835 | 2020 | QAK{nt:Acet}{ct:Acet} | acetylated-QAK | Acetylation | Acetylation | Linear | L | None | 3 | Antibacterial, Antibiofilm | 38.28 % Hemolysis at 200 µg/ml | Rabbit | Synthesized-Qak | NA | NA | ||
| 32654770 | 2020 | {nnr:Aβ}LLKRIKTLL{ct:Amid} | Ano-1β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | G{nnr:Aβ}LKRIKTLL{ct:Amid} | Ano-2β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GL{nnr:Aβ}KRIKTLL{ct:Amid} | Ano-3β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLL{nnr:Aβ}RIKTLL{ct:Amid} | Ano-4β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLK{nnr:Aβ}IKTLL{ct:Amid} | Ano-5β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKR{nnr:Aβ}KTLL{ct:Amid} | Ano-6β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRI{nnr:Aβ}TLL{ct:Amid} | Ano-7β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRIK{nnr:Aβ}LL{ct:Amid} | Ano-8β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRIKT{nnr:Aβ}L{ct:Amid} | Ano-9β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRIKTL{nnr:Aβ}{ct:Amid} | Ano-10β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | {nnr:Aβ}LLKRIK{nnr:Aβ}LL{ct:Amid} | Ano-1β8β | Amidation | Free | Linear | L | Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Modified With Β-Ala In Anoplin | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32654770 | 2020 | GLLKRIKTLL{ct:Amid} | Anoplin | Amidation | Free | Linear | L | None | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at >256 μM | mouse | Venom Sac Of Solitary Spider Wasps | 30 mM SDS = α-Helix | Low hemolytic | ||
| 32630734 | 2020 | FIQHLIPLIPHAIQGIKDIF{ct:Amid} | Kassiniatuerin-3 | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Antibiofilm, Antiproliferation | ~2 % Hemolysis at 160 μM | Horse | Frog Kassina Senegalensis | aqueous = Random coil, 50% TFE = Helical | Low hemolytic | ||
| 32534825 | 2020 | GATIRAVNSR | PepGAT | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 50 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | KAANRIKYFQ | PepKAA | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 50 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | GATIRAVNSR | PepGAT | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 100 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | KAANRIKYFQ | PepKAA | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 100 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | GATIRAVNSR | PepGAT | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 250 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | KAANRIKYFQ | PepKAA | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 250 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | GATIRAVNSR | PepGAT | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 500 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32534825 | 2020 | KAANRIKYFQ | PepKAA | Free | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0 % Hemolysis at 500 µg/mL | Rabbit | Synthetic Amps | Random coil | Non-hemolytic | ||
| 32590058 | 2020 | K{d}FW{d}SLLK{d}KALRLW{d}ANVL{ct:Amid} | CPF-2 | Amidation | Free | Linear | Mix | None | 17 | Antibiofilm, Antibacterial | 100 % Hemolysis at 128 μg/mL | Mouse | Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ) | 50% TFE = Random coil | NA | ||
| 32786271 | 2020 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | HC1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 33 % Hemolysis at 50 μM | Mouse | Snake Hydrophis Cyanocinctus | water = Random coil, 60 mM SDS solution = α-helica | NA | ||
| 32786271 | 2020 | K{d}FFK{d}R{d}LLK{d}SVR{d}R{d}AVK{d}K{d}FR{d}K{d}{ct:Amid} | HC1-D1 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 28 % Hemolysis at 50 μM | Mouse | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = Random coil | NA | ||
| 32786271 | 2020 | K{d}ffK{d}R{d}L{d}L{d}K{d}S{d}V{d}R{d}R{d}A{d}V{d}K{d}K{d}F{d}R{d}K{d}{ct:Amid} | HC1-D2 | Amidation | Free | Linear | D | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 31 % Hemolysis at 50 μM | Mouse | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = α-Helix | NA | ||
| 32786271 | 2020 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | Mix | None | 30 | Antimicrobial, Anti-inflammatory, Antibiofilm | 37 % Hemolysis at 50 μM | Mouse | Hc-Cath Derivatives | amphipathic α-Helical | NA | ||
| 32786271 | 2020 | KFFKRLLKSVRRAVKKFRK{ct:Amid} | HC1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 13 % Hemolysis at 50 μM | Human | Snake Hydrophis Cyanocinctus | water = Random coil, 60 mM SDS solution = α-helica | NA | ||
| 32786271 | 2020 | K{d}FFK{d}R{d}LLK{d}SVR{d}R{d}AVK{d}K{d}FR{d}K{d}{ct:Amid} | HC1-D1 | Amidation | Free | Linear | Mix | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 9 % Hemolysis at 50 μM | Human | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = Random coil | NA | ||
| 32786271 | 2020 | K{d}ffK{d}R{d}L{d}L{d}K{d}S{d}V{d}R{d}R{d}A{d}V{d}K{d}K{d}F{d}R{d}K{d}{ct:Amid} | HC1-D2 | Amidation | Free | Linear | D | None | 19 | Antimicrobial, Anti-inflammatory, Antibiofilm | 12 % Hemolysis at 50 μM | Human | Hc-Cath Derivatives | water = Random coil, 60 mM SDS solution = α-Helix | NA | ||
| 32786271 | 2020 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | Mix | None | 30 | Antimicrobial, Anti-inflammatory, Antibiofilm | 16 % Hemolysis at 50 μM | Human | Hc-Cath Derivatives | amphipathic α-Helical | NA | ||
| 32841003 | 2020 | GITDLRGMLKRLKKMK | Sm-A1 | Free | Free | Linear | L | None | 16 | Antibacterial, Antibiofilm | 10 % Hemolysis at 80 μM | Human | Derived From Turbot Viscera Hydrolysate | α-Helix | Low hemolytic | ||
| 32967333 | 2020 | ALWKKLLKK-{nnr:Cha}{ct:Amid} | DMPC-10A | Amidation | Free | Linear | L | Cha = Cyclohexanylalanine | 10 | Antibacterial, Antibiofilm | ≥20 % Hemolysis at 128 μM | Horse | Derived From A Dermaseptin (Phyllomedusa Frogs) | amphipathic environment = α-Helix | NA | ||
| 32967333 | 2020 | AL{d}WK{d}K{d}L{d}L{d}K{d}K{d}-{nnr:Cha}{ct:Amid} | DMPC-10B | Amidation | Free | Linear | Mix | Cha = Cyclohexanylalanine | 10 | Antibacterial, Antibiofilm | 0 % Hemolysis at 128 μM | Horse | Modificaiton Of Dmpc-10A | TFE = α-Helix | Non-hemolytic | ||
| 33194795 | 2020 | RFRLPFRRPPIRIHPPPFYPPFRRFL{ct:Amid} | ChBac3.4-NH2(caprine proline-rich bactenecin) | Amidation | Free | Linear | L | None | 26 | Antitumor, Antimicrobial, Antibiofilm | 25 ± 2 % Hemolysis at 64 μM | Human | Domestic Goat Capra Hircus | NA | NA | ||
| 33194795 | 2020 | RFRRFRLPFRRIHPPPFVRIHPPPFYRRFL{ct:Amid} | RFR-ChBac3.4-1-NH2 | Amidation | Free | Linear | L | None | 30 | Antibacterial, Antibiofilm | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Full-Lenght Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRRFRLPFRRPPIRIH{ct:Amid} | RFR-ChBac3.4(1-14)-NH2 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Truncated Variants | NA | Low hemolytic | ||
| 33193152 | 2020 | FLSLIPKIAGGIAALVKNL{ct:Amid} | Phylloseptin-PV1 (PPV1) | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Antiproliferative, Antibiofilm | ≥50 % Hemolysis at 32 μM | Horse | White-Lined Leaf Frog Phyllomedusa Vaillantii | aqueous = Random coil, 50% TFE = α-Helix | NA | ||
| 33193152 | 2020 | FLSLIPKIAGGIAALVKNL{ct:Amid} | Phylloseptin-PV1 (PPV1) | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Antiproliferative, Antibiofilm | ≥95 % Hemolysis at 64 μM | Horse | White-Lined Leaf Frog Phyllomedusa Vaillantii | aqueous = Random coil, 50% TFE = α-Helix | NA | ||
| 33233541 | 2020 | FFGSLLSLGSKLLPSVFKLFQRKKE{ct:Amid} | Css54 | Amidation | Free | Linear | L | None | 25 | Antibacterial, Antibiofilm | 40 % Hemolysis at 16 μM | Sheep | Scorpion Venom Of Centruroides Suffusus | aqueous(10mM sodium phosphate) = Random coil, TFE and SDS = α-Helix | NA | ||
| 33291521 | 2020 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 10 % Hemolysis at 156 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 10 % Hemolysis at 11.6 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 10 % Hemolysis at 22.3 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 10 % Hemolysis at 32.8 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 50 % Hemolysis at >200 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | Low hemolytic | ||
| 33291521 | 2020 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 50 % Hemolysis at 10.9 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 50 % Hemolysis at 167.6 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33291521 | 2020 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, Antibiofilm | 50 % Hemolysis at 86.3 μM | Human | Synthetic Temporin-Gha (Gha) Analogue | α-Helical | NA | ||
| 33296183 | 2021 | FLK{nnr:α-(4-pentenyl)-Ala}LKKLL{ct:Amid} | Feleucin-K59 | Amidation | Free | Linear | L | α-(4-pentenyl)-Ala | 9 | Antibacterial, Antibiofilm | ≥60 % Hemolysis at 128 μg/mL | Mouse | Feleucin-K3 Analogues (Frog Bombina Orientalis) | TFE = α-Helix | NA | ||
| 33532575 | 2021 | KYKKALKKLAKLL | L-SB1 | Free | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm | MHC at >2000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | K{d}Y{d}K{d}K{d}A{d}L{d}K{d}K{d}L{d}A{d}K{d}L{d}L{d} | D-SB1 | Free | Free | Linear | D | None | 13 | Antibacterial. Antibiofilm | MHC at >2000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | VQWRAIRVRVIR | L-DJK5 | Free | Free | Linear | L | None | 12 | Antibacterial. Antibiofilm | MHC at >2000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | V{d}Q{d}W{d}R{d}A{d}I{d}R{d}V{d}R{d}V{d}I{d}R{d} | D-DJK5 | Free | Free | Linear | D | None | 12 | Antibacterial. Antibiofilm | MHC at 1000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | ILPWKWPWWPWRR | L-Indo | Free | Free | Linear | L | None | 13 | Antibacterial. Antibiofilm | MHC at 125 μg/mL | Human | Derived From Bovin | PB and 20%TFE = α-Helical | NA | ||
| 33532575 | 2021 | I{d}L{d}P{d}W{d}K{d}W{d}P{d}W{d}W{d}P{d}W{d}R{d}R{d} | D-Indo | Free | Free | Linear | D | None | 13 | Antibacterial. Antibiofilm | MHC at 125 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | NA | ||
| 33532575 | 2021 | KLKLKLKLKLKLKLKLKKLKKLKKLKKLKKLKKLKKL | L-G3KL | Free | Free | Branched | L | None | 37 | Antibacterial. Antibiofilm | MHC at 1000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d} | D-G3KL | Free | Free | Branched | D | None | 37 | Antibacterial. Antibiofilm | MHC at 1000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | OFOFOFOFKBLKBLKKLK{ct:C10} | L-TNS18 | Free | Free | Branched | L | None | 18 | Antibacterial. Antibiofilm | MHC at 1000 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Non-hemolytic | ||
| 33532575 | 2021 | O{d}F{d}O{d}F{d}O{d}F{d}O{d}F{d}K{d}B{d}L{d}K{d}B{d}L{d}K{d}K{d}L{d}K{d}{ct:C10} | D-TNS18 | Free | Free | Branched | D | None | 18 | Antibacterial. Antibiofilm | MHC at 500 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | Low hemolytic | ||
| 33532575 | 2021 | KLKLKLKLKLKLKLKLKKLKKLKKLKKLKLLKLLKKLL | L-T25 | Free | Free | Branched | L | None | 38 | Antibacterial. Antibiofilm | MHC at 62.5 μg/mL | Human | Synthetic Peptide | PB and 20%TFE = α-Helical | NA | ||
| 33532575 | 2021 | K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}L{d}L{d}K{d}L{d}L{d}K{d}K{d}L{d}L{d} | D-T25 | Free | Free | Branched | D | None | 38 | Antibacterial. Antibiofilm | MHC at 125 μg/mL | Human | Synthetic Peptide | NA | NA | ||
| 32812694 | 2021 | FALGAVTKVLPKLFCLITRKC | Brevinin-1H | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm, Antifungal | >20 % Hemolysis at 32 µM | Horse | Frog Amolops Hainanensis | Helix | NA | ||
| 32812694 | 2021 | FALGAVTKVLPKLFCLITRKC | Brevinin-1H | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm, Antifungal | 50 % Hemolysis at 53.12 µM | Horse | Frog Amolops Hainanensis | Helix | NA | ||
| 32812694 | 2021 | FALGAVTKVLPKLFCLITRKC | Brevinin-1H | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm, Antifungal | 9.49 % Hemolysis at 4 µM | Horse | Frog Amolops Hainanensis | Helix | NA | ||
| 32812694 | 2021 | FALGAVTCLIRTKCKVLPKLF | Brevinin-1Ha | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 22.1 % Hemolysis at 128 µM | Horse | Brevinin-1H Analogues | NA | NA | ||
| 32812694 | 2021 | FALGAVTKVLYKLFCLITRKC | Brevinin-1HY | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 28.48 % Hemolysis at 4 µM | Horse | Brevinin-1H Analogues | Helix | NA | ||
| 33141035 | 2021 | RIIDLLWRVRRPQKPKFVTVWVR | PMAP-23 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | ≤4 % Hemolysis at 1280 μg/mL | Mouse | Porcine Myeloid | two α-Helical | Non-hemolytic | ||
| 33141035 | 2021 | RIIDRLWRVRRPQKPKFVIVWVR | PMAP-23R | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | ≤4 % Hemolysis at 1280 μg/mL | Mouse | Pmap-23 Analogs | NA | Non-hemolytic | ||
| 33141035 | 2021 | RIIDRLWRVRRPQKPKFVIVWVR-K-{nnr:Dec}{ct:Dec} | PMAP-23RI-Dec | Dec | Free | Linear | L | Dec = Decanoic acid | 24 | Antibacterial, Antibiofilm | ≤4 % Hemolysis at 1280 μg/mL | Mouse | Pmap-23 Analogs With Decanoic Acid | NA | Non-hemolytic | ||
| 33242568 | 2021 | KKCNFFCKLKKKVKSVGSRNLIGSATHHHRIYRV | PN-CATH1 | Free | Free | Linear | L | None | 34 | Antibacterial, Antifungal, Antibiofilm, Anti-inflammatory, anitoxidant | 5.9 % Hemolysis at 200 μg/mL | Mouse | Black-Spotted Frog, Pelophylax Nigromaculata | SDS = α-Helical | Low hemolytic | ||
| 33242568 | 2021 | EGCNILCLLKRKVKAVKNVVKNVVKSVVG | PN-CATH2 | Free | Free | Linear | L | None | 29 | Antibacterial, Antifungal, Antibiofilm, Anti-inflammatory, anitoxidant | 7.5 % Hemolysis at 200 μg/mL | Mouse | Black-Spotted Frog, Pelophylax Nigromaculata | SDS = α-Helical | Low hemolytic | ||
| 34069651 | 2021 | LKLLKKLL{nt:α-(4-pentenyl)-Ala}{ct:Amid} | Feleucin-K65 | Amidation | α-(4-pentenyl)-Ala | Linear | L | α-(4-pentenyl)-Ala | 9 | Antimicrobial, Antibiofilm | 9.08 % Hemolysis at 64 μg/ml | Mouse | Feleucin-K3 Analogs (Frog Bombina Orientalis) | 50% TFE = α-Helical | NA | ||
| 34069651 | 2021 | LKLLKKLL{nt:α-(4-pentenyl)-Ala}{ct:Amid} | Feleucin-K65 | Amidation | α-(4-pentenyl)-Ala | Linear | L | α-(4-pentenyl)-Ala | 9 | Antimicrobial, Antibiofilm | 31.6 % Hemolysis at 128 μg/ml | Mouse | Feleucin-K3 Analogs (Frog Bombina Orientalis) | 50% TFE = α-Helical | NA | ||
| 34069651 | 2021 | FLKLLKKL{nnr:α-(4-pentenyl)-Ala}{ct:Amid} | Feleucin-K70 | Amidation | Free | Linear | L | α-(4-pentenyl)-Ala | 9 | Antimicrobial, Antibiofilm | 1 % Hemolysis at 128 μg/ml | Mouse | Feleucin-K3 Analogs (Frog Bombina Orientalis) | 50% TFE = α-Helical | Non-hemolytic | ||
| 34073939 | 2021 | GILGKLWEGVKSIF{ct:Amid} | Hp1404 | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 49.2 % Hemolysis at 50 µM | Mouse | Scorpion Heterometrus Petersii | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | NA | ||
| 34073939 | 2021 | GILGKLWEGVKSIV{ct:Amid} | Hp1404-V | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 50 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 34073939 | 2021 | GILGKLWEGVKSIL{ct:Amid} | Hp1404-L | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 45.8 % Hemolysis at 50 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | NA | ||
| 34073939 | 2021 | GILGKLWEGVKSIL{ct:Amid} | Hp1404-L | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 21.3 % Hemolysis at 25 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | NA | ||
| 34073939 | 2021 | GILGKLWEGVKSII{ct:Amid} | Hp1404-I | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 25 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | Non-hemolytic | ||
| 34073939 | 2021 | GILGKLWEGVKSIW{ct:Amid} | Hp1404-W | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 15.9 % Hemolysis at 50 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | NA | ||
| 34073939 | 2021 | GILGKLWEGVKSIW{ct:Amid} | Hp1404-W | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 1.7 % Hemolysis at 25 µM | Mouse | Hp404 Analogs | 10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix | Low hemolytic | ||
| 34220763 | 2021 | WKKLKKLLKKLKKL{nt:Acet}{ct:Amid} | pepD2 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 9.6 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | WKKLKKLLKKL{nt:Acet}{ct:Amid} | pepD3 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 3.15 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | PE/PG liposomes = α-Helical | Low hemolytic | ||
| 34220763 | 2021 | WKKVKKVVKKVKKV{nt:Acet}{ct:Amid} | pepV2 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0.31 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Non-hemolytic | ||
| 34220763 | 2021 | WKKIKKIIKKIKKI{nt:Acet}{ct:Amid} | pepI2 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0.27 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Non-hemolytic | ||
| 34220763 | 2021 | WRRLRRLLRRLRRL{nt:Acet}{ct:Amid} | pepR2 | Amidation | Acetylation | Linear | L | None | 14 | Antibacterial, Antibiofilm | 105.65 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | W{nnr:O}{nnr:O}L{nnr:O}{nnr:O}LL{nnr:O}{nnr:O}L{nnr:O}{nnr:O}L{nt:Acet}{ct:Amid} | pepO2 | Amidation | Acetylation | Linear | L | O = L-Ornithine | 14 | Antibacterial, Antibiofilm | 0.23 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Non-hemolytic | ||
| 34220763 | 2021 | WK{d}K{d}L{d}K{d}K{d}L{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}{nt:Acet}{ct:Amid} | pepdD2 | Amidation | Acetylation | Linear | Mix | None | 14 | Antibacterial, Antibiofilm | 2.9 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | MY{d}R{d}-WKKLKKLLKKLKKL{nt:Myr = myristyl}{ct:Amid} | pepD2M | Amidation | Myr = myristyl | Linear | L | None | 14 | Antibacterial, Antibiofilm | 93.63 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | PA{d}L{d}-WKKLKKLLKKLKKL{nt:Pal = palmitoyl}{ct:Amid} | pepD2P | Amidation | Pal = palmitoyl | Linear | L | None | 14 | Antibacterial, Antibiofilm | 83.45 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | ST{d}E{d}-WKKLKKLLKKLKKL{nt:Ste = stearyl}{ct:Amid} | pepD2S | Amidation | Ste = stearyl | Linear | L | None | 14 | Antibacterial, Antibiofilm | 60.7 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | OC{d}T{d}-WKKLKKLLKKL{nt:Oct = octanoyl}{ct:Amid} | pepD3O | Amidation | Oct = octanoyl | Linear | L | None | 11 | Antibacterial, Antibiofilm | 86.03 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | HE{d}X{d}-WKKLKKLLKKL{nt:Hex = hexanoyl}{ct:Amid} | pepD3H | Amidation | Hex = hexanoyl | Linear | L | None | 11 | Antibacterial, Antibiofilm | 54.07 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34220763 | 2021 | BU{d}T{d}-WKKLKKLLKKL{nt:But = butanoyl}{ct:Amid} | pepD3B | Amidation | But = butanoyl | Linear | L | None | 11 | Antibacterial, Antibiofilm | 7.89 % Hemolysis at 256 μg/mL | Rat | De Novo Designed Peptide | NA | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 50 % Hemolysis at 886.5 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 1 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 2 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0.4 % Hemolysis at 4 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0.7 % Hemolysis at 8 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 1.4 % Hemolysis at 16 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 1.5 % Hemolysis at 32 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 1.8 % Hemolysis at 64 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 2.4 % Hemolysis at 128 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF | Kn2-5R | Free | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 10.6 % Hemolysis at 256 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | Low hemolytic | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 50 % Hemolysis at 16.77 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0.1 % Hemolysis at 1 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 0.3 % Hemolysis at 2 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 2 % Hemolysis at 4 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 2.5 % Hemolysis at 8 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 5.4 % Hemolysis at 16 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 16.9 % Hemolysis at 32 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 40.3 % Hemolysis at 64 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 99.3 % Hemolysis at 128 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FIRRIARLLRRIF{ct:Amid} | Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 13 | Anti-Salmonella, Antibiofilm | 99.5 % Hemolysis at 256 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 50 % Hemolysis at 33.26 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 1 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0 % Hemolysis at 2 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0.4 % Hemolysis at 4 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0.5 % Hemolysis at 8 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 0.9 % Hemolysis at 16 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 2.5 % Hemolysis at 32 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 8.7 % Hemolysis at 64 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 23.6 % Hemolysis at 128 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid} | dKn2-5R-NH2 | Amidation | Free | Linear | D | None | 13 | Anti-Salmonella, Antibiofilm | 65.6 % Hemolysis at 256 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 50 % Hemolysis at 0.99 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 6.1 % Hemolysis at 1 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 15 % Hemolysis at 2 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 33.7 % Hemolysis at 4 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 61.6 % Hemolysis at 8 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 96.2 % Hemolysis at 16 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 97.6 % Hemolysis at 32 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 97.9 % Hemolysis at 64 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 99.8 % Hemolysis at 128 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34361810 | 2021 | FFFIRRIARLLRRIF{ct:Amid} | 2F-Kn2-5R-NH2 | Amidation | Free | Linear | L | None | 15 | Anti-Salmonella, Antibiofilm | 100 % Hemolysis at 256 μM | Sheep | Variants Of The Scorpion Venom Peptide Bmkn-2 | α-Helix | NA | ||
| 34180670 | 2021 | GLLKRIKTLL | anoplin | Free | Free | Linear | L | None | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at ≥512 μM | Human | Venom Of Wasps (Anoplius Samariensis) | α-Helical | Non-hemolytic | ||
| 34180670 | 2021 | KWWKKWKKWW | A-21 | Free | Free | Linear | L | None | 10 | Antibacterial, Antibiofilm | 10 % Hemolysis at 134.38 μM | Human | Anoplin Analogues | water = Random coil, 50% trifluoroethanol = α-Helical | NA | ||
| 34342438 | 2021 | RPFTRAQWFAIQHISPRTIAMRAINNYRWR | hECP30 | Free | Free | Linear | L | None | 30 | Antimicrobial, Antibiofilm | 44 ± 4 % Hemolysis at 250 μM | Horse | Human Rnase 3 Eosinophil Cationic Protein (Ecp) Fragment | aqueous = Random coil, SDS micelles (1 mM) = α-Helical | NA | ||
| 34028137 | 2021 | VRLLRRRI{nt:H}{ct:Amid} | SAMP-A4 | Amidation | H | Linear | L | None | 8 | Antibacterial, Antifungal, Antibiofilm | 5 % Hemolysis at 69.26 μg/ml | Human | Synthesized Antimicrobial Peptide A4 | NA | Low hemolytic | ||
| 34028137 | 2021 | VRLLRRRI{nt:Acet}{ct:Amid} | SAMP-A4-C2 | Amidation | Acetylation | Linear | L | None | 8 | Antibacterial, Antifungal, Antibiofilm | 5 % Hemolysis at 34.56 μg/ml | Human | Samp-A4 Analogue | NA | Low hemolytic | ||
| 34028137 | 2021 | VRLLRRRI{nt:Butyryl}{ct:Amid} | SAMP-A4-C4 | Amidation | Butyryl | Linear | L | None | 8 | Antibacterial, Antifungal, Antibiofilm | 5 % Hemolysis at 73.84 μg/ml | Human | Samp-A4 Analogue | NA | Low hemolytic | ||
| 34028137 | 2021 | VRLLRRRI{nt:Hexanoyl}{ct:Amid} | SAMP-A4-C6 | Amidation | Hexanoyl | Linear | L | None | 8 | Antibacterial, Antifungal, Antibiofilm | 5 % Hemolysis at 84.98 μg/ml | Human | Samp-A4 Analogue | NA | Low hemolytic | ||
| 34028137 | 2021 | VRLLRRRI{nt:PEG}{ct:Amid} | SAMP-A4-PEG3 | Amidation | PEG | Linear | L | None | 8 | Antibacterial, Antifungal, Antibiofilm | 5 % Hemolysis at 19.95 μg/ml | Human | Samp-A4 Analogue | NA | Low hemolytic | ||
| 34028137 | 2021 | VRLLRRRI{nt:Gluconyl}{ct:Amid} | SAMP-A4-GlcA | Amidation | Gluconyl | Linear | L | None | 8 | Antibacterial, Antifungal, Antibiofilm | 5 % Hemolysis at 22.16 μg/ml | Human | Samp-A4 Analogue | NA | Low hemolytic | ||
| 34738013 | 2021 | FIPLVSGLFSKLL{ct:Amid} | Temporin-FL | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 157.4 μM | Horse | Frog Pelophylax Nigromaculatus | 50%TFE/NH4Ac = Helix | NA | ||
| 34738013 | 2021 | FIPLVSGLFKLL{ct:Amid} | Temporin-FLa | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 74.02 μM | Horse | Temporin-Fl Truncated Analogues | 50%TFE/NH4Ac = Helix | NA | ||
| 34738013 | 2021 | FIPVSGLFKLL{ct:Amid} | Temporin-FLb | Amidation | Free | Linear | L | None | 11 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 356 μM | Horse | Temporin-Fl Truncated Analogues | 50%TFE/NH4Ac = Helix | Low hemolytic | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:OH} | RR4-OH | OH | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 3.2 ± 1.0 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | WIRRIKKWIRRVHK{ct:Amid} | RR2-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 13.0 ± 1.7 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRKRK{ct:Amid} | RR3-NH2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 19.0 ± 3.3 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:Amid} | RR4-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 64.3 ± 5.4 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VFWRRIRVWVIR{ct:Amid} | LJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 28.4 ± 1.9 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 35.1 ± 8.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RIVWVRIRRWFV{ct:Amid} | RJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 19.2 ± 3.1 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm, Anti-inflammatory | 79.0 ± 0.6 % Hemolysis at 150 μM | Horse | Ll-37 Derivatives Synthetic Peptide | α-Helical | NA | ||
| 34819923 | 2021 | WKKIRVRLSA{ct:Amid} | SB056 | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 1.7 ± 0.2 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | GILGKLWEGVKSIF{ct:Amid} | HP1404 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 100.0 ± 0.5 % Hemolysis at 150 μM | Horse | Scorpion Heterometrus Petersii | NA | NA | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid} | HP1404 T1-D | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial, Antibiofilm | 0.3 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid} | HP1404 T1-E | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 0.8 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | FLFSLIPHAIGGLISAFK{ct:Amid} | AamAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.00 ± 1.3 % Hemolysis at 150 μM | Horse | Scorpion Venom Antimicrobial Peptide | NA | NA | ||
| 34819923 | 2021 | FLFSLIPKAIGGLISAFK{ct:Amid} | AamAP-S1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.00 ± 4.9 % Hemolysis at 150 μM | Horse | Aamap1 Analog | NA | NA | ||
| 34819923 | 2021 | FLFSLIPRAIGGLISAFK{ct:Amid} | AamAP-R | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.00 ± 4.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antibiofilm | 35.2 ± 1.1 % Hemolysis at 150 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAK{ct:Amid} | Magainin 2(1-10) | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0.0 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 95.1 ± 5.0 % Hemolysis at 150 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid} | BP525 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 3.1 ± 1.0 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid} | BP526 | Amidation | C3H7CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 8.3 ± 0.7 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid} | BP527 | Amidation | C5H11CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 62.2 ± 4.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid} | BP528 | Amidation | C11H23CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 92.1 ± 5.7 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid} | BP529 | Amidation | HOC11H22CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 7.2 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 35.6 ± 4.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRVIRK{ct:Amid} | HH15 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 2.3 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQWRIRVRVIKK{ct:Amid} | 1026 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 7.6 ± 0.8 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | KQFRIRVRV{ct:Amid} | 1029 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 2.3 ± 0.7 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQFRIRVRIVIRK{ct:Amid} | 1036 | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 6.5 ± 0.6 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | KRFRIRVRV{ct:Amid} | 1037 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 2.4 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | FRIRVRV{ct:Amid} | FV7 | Amidation | Free | Linear | L | None | 7 | Antimicrobial, Antibiofilm | 3.7 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV7-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 6.3 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA-OH{ct:OH} | RR4-OH | OH | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 9.8 ± 3.7 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | WIRRIKKWIRRVHK{ct:Amid} | RR2-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 14.0 ± 1.8 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRKRK{ct:Amid} | RR3-NH2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 30.8 ± 4.2 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:Amid} | RR4-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 85.0 ± 5.7 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VFWRRIRVWVIR{ct:Amid} | LJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 43.9 ± 3.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 64.4 ± 9.4 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RIVWVRIRRWFV{ct:Amid} | RJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 29.6 ± 2.2 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm, Anti-inflammatory | 96.1 ± 1.8 % Hemolysis at 250 μM | Horse | Ll-37 Derivatives Synthetic Peptide | α-Helical | NA | ||
| 34819923 | 2021 | WKKIRVRLSA{ct:Amid} | SB056 | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 1.8 ± 0.3 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | GILGKLWEGVKSIF{ct:Amid} | HP1404 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 100.0 ± 3.9 % Hemolysis at 250 μM | Horse | Scorpion Heterometrus Petersii | NA | NA | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid} | HP1404 T1-D | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial, Antibiofilm | 0.8 ± 1.1 % Hemolysis at 250 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid} | HP1404 T1-E | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 0.7 ± 0.4 % Hemolysis at 250 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | FLFSLIPHAIGGLISAFK{ct:Amid} | AamAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 4.1 % Hemolysis at 250 μM | Horse | Scorpion Venom Antimicrobial Peptide | NA | NA | ||
| 34819923 | 2021 | FLFSLIPKAIGGLISAFK{ct:Amid} | AamAP-S1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 2.1 % Hemolysis at 250 μM | Horse | Aamap1 Analog | NA | NA | ||
| 34819923 | 2021 | FLFSLIPRAIGGLISAFK{ct:Amid} | AamAP-R | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 10.5 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antibiofilm | 54.5 ± 3.7 % Hemolysis at 250 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAK{ct:Amid} | Magainin 2(1-10) | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0.0 ± 0.2 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 100.0 ± 4.4 % Hemolysis at 250 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid} | BP525 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 3.8 ± 0.8 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid} | BP526 | Amidation | C3H7CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 20.4 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid} | BP527 | Amidation | C5H11CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 73.6 ± 1.1 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid} | BP528 | Amidation | C11H23CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 96.6 ± 3.1 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid} | BP529 | Amidation | HOC11H22CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 12.5 ± 0.6 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 43.0 ± 0.2 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRVIRK{ct:Amid} | HH15 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 4.5 ± 1.9 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQWRIRVRVIKK{ct:Amid} | 1026 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 10.8 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | KQFRIRVRV{ct:Amid} | 1029 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 3.5 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQFRIRVRIVIRK{ct:Amid} | 1036 | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 11.0 ± 1.6 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRV{ct:Amid} | 1037 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 3.3 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | FRIRVRV{ct:Amid} | FV7 | Amidation | Free | Linear | L | None | 7 | Antimicrobial, Antibiofilm | 4.4 ± 0.3 % Hemolysis at 250 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV7-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 8.0 ± 1.3 % Hemolysis at 250 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:OH} | RR4-OH | OH | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 17.8 ± 0.3 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WIRRIKKWIRRVHK{ct:Amid} | RR2-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 17.9 ± 0.4 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRKRK{ct:Amid} | RR3-NH2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 37.3 ± 4.4 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:Amid} | RR4-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 100.0 ± 5.4 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VFWRRIRVWVIR{ct:Amid} | LJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 72.4 ± 8.9 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 71.0 ± 7.1 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RIVWVRIRRWFV{ct:Amid} | RJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 50.2 ± 5.4 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm, Anti-inflammatory | 100.0 ± 1.7 % Hemolysis at 375 μM | Horse | Ll-37 Derivatives Synthetic Peptide | α-Helical | NA | ||
| 34819923 | 2021 | WKKIRVRLSA{ct:Amid} | SB056 | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 2.3 ± 0.7 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | GILGKLWEGVKSIF{ct:Amid} | HP1404 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 100.0 ± 0.7 % Hemolysis at 375 μM | Horse | Scorpion Heterometrus Petersii | NA | NA | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid} | HP1404 T1-D | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial, Antibiofilm | 1.3 ± 0.2 % Hemolysis at 375 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid} | HP1404 T1-E | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 1.5 ± 0.3 % Hemolysis at 375 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | FLFSLIPHAIGGLISAFK{ct:Amid} | AamAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 4.4 % Hemolysis at 375 μM | Horse | Scorpion Venom Antimicrobial Peptide | NA | NA | ||
| 34819923 | 2021 | FLFSLIPKAIGGLISAFK{ct:Amid} | AamAP-S1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 2.9 % Hemolysis at 375 μM | Horse | Aamap1 Analog | NA | NA | ||
| 34819923 | 2021 | FLFSLIPRAIGGLISAFK{ct:Amid} | AamAP-R | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 3.1 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antibiofilm | 71.1 ± 6.0 % Hemolysis at 375 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAK{ct:Amid} | Magainin 2(1-10) | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0.0 ± 0.7 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 100.0 ± 2.5 % Hemolysis at 375 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid} | BP525 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 10.0 ± 5.9 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid} | BP526 | Amidation | C3H7CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 46.8 ± 3.3 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid} | BP527 | Amidation | C5H11CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 100.0 ± 2.6 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid} | BP528 | Amidation | C11H23CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 99.1 ± 8.0 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid} | BP529 | Amidation | HOC11H22CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 39.0 ± 1.1 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 45.9 ± 4.9 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRVIRK{ct:Amid} | HH15 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 4.0 ± 0.4 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQWRIRVRVIKK{ct:Amid} | 1026 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 14.5 ± 5.5 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KQFRIRVRV{ct:Amid} | 1029 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 3.4 ± 0.6 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQFRIRVRIVIRK{ct:Amid} | 1036 | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 17.3 ± 1.3 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRV{ct:Amid} | 1037 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 4.9 ± 0.2 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | FRIRVRV{ct:Amid} | FV7 | Amidation | Free | Linear | L | None | 7 | Antimicrobial, Antibiofilm | 9.5 ± 1.4 % Hemolysis at 375 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV7-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 9.7 ± 0.6 % Hemolysis at 375 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34508563 | 2021 | FLGALFKVASKLVPAAICSISKKC | Brevinin-1HL | Free | Free | Linear | L | None | 24 | Antimicrobial, Anticancer, Antibiofilm | 50 % Hemolysis at 11.5 ± 0.2 μM | Horse | Broad-Folded Frog, Hylarana Latouchii | aqueous = Random coil, 50% TFE = α-Helical | NA | ||
| 34508563 | 2021 | FFPLIFGALSSILPKIL | Temporin-HLa | Free | Free | Linear | L | None | 17 | Antimicrobial, Anticancer, Antibiofilm | 50 % Hemolysis at 31.4 ± 0.7 μM | Horse | Broad-Folded Frog, Hylarana Latouchii | aqueous = Random coil, 50% TFE = α-Helical | NA | ||
| 34508563 | 2021 | FLQHIIGALSHIF | Temporin-HLb | Free | Free | Linear | L | None | 13 | Antimicrobial, Anticancer, Antibiofilm | 50 % Hemolysis at 18.6 ± 10.0 mM | Horse | Broad-Folded Frog, Hylarana Latouchii | aqueous = Random coil, 50% TFE = α-Helical | Low hemolytic | ||
| 34959645 | 2021 | SKEKIGKEFKRIVQRIKDFLRNLV{ct:Amid} | SK-24 | Amidation | Free | Linear | L | None | 24 | Antibacterial, Antibiofilm | <25 % Hemolysis at 200 μM | Human | Ll-37 Derived Peptide | PBS, 60mMSDS = Helical | Low hemolytic | ||
| 34959645 | 2021 | GIKEFKRIVQRIKDFLRNLV{ct:Amid} | GI-20 | Amidation | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 50 % Hemolysis at ~160 μM | Human | Ll-37 Derived Peptide | PBS, 60mMSDS = Helical | NA | ||
| 34959645 | 2021 | GFKRIVQRIKDFLRNLV{ct:Amid} | GF-17 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 50 % Hemolysis at 175 μM | Human | Ll-37 Derived Peptide | PBS, 60mMSDS = Helical | NA | ||
| 34959645 | 2021 | G{nnr:X}KRlVQRlKD{nnr:X}LRNLV{ct:Amid} | 17BIPHE2 | Amidation | Free | Linear | Mix | X = biphenylalanines | 17 | Antibacterial, Antibiofilm | 50 % Hemolysis at ~200 μM | Human | Ll-37 Derived Peptide | PBS = distorted, 60mMSDS = Helical | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 50 % Hemolysis at 76.55 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 2.73 % Hemolysis at 2 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 4.31 % Hemolysis at 4 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 7.47 % Hemolysis at 8 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34825276 | 2022 | INWL-{nnr:Dap}-LG-{nnr:Dap}-MVIDAL{ct:Amid} | PMPII | Amidation | Free | Linear | L | Dap = L-2,3-Diamino-propionic | 14 | Antibacterial, Antifungal, Antibiofilm | 0 % Hemolysis at 256 μM | Mouse | Mpii Analogs | 10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical | Non-hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{ct:Amid} | RW-BP-100 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal, Antibiofilm | 3.10 ± 0.77 % Hemolysis at 50 μg/mL | Sheep | Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues | NA | NA | ||
| 35145500 | 2022 | RRLF{d}RRILRWL{ct:Amid} | RW-BP100-4D* | Amidation | Free | Linear | Mix | None | 11 | Antibacterial, Antifungal, Antibiofilm | 0.11 ± 0.19 % Hemolysis at 50 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | Low hemolytic | ||
| 35145500 | 2022 | RRLFRRILRWL{ct:Amid} | RW-BP-100 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal, Antibiofilm | 4.70 ± 0.49 % Hemolysis at 100 μg/mL | Sheep | Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues | NA | NA | ||
| 35145500 | 2022 | RRLF{d}RRILRWL{ct:Amid} | RW-BP100-4D* | Amidation | Free | Linear | Mix | None | 11 | Antibacterial, Antifungal, Antibiofilm | 3.69 ± 0.01 % Hemolysis at 100 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRWL{ct:Amid} | RW-BP-100 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal, Antibiofilm | 41.82 ± 2.27 % Hemolysis at 150 μg/mL | Sheep | Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues | NA | NA | ||
| 35145500 | 2022 | RRLF{d}RRILRWL{ct:Amid} | RW-BP100-4D* | Amidation | Free | Linear | Mix | None | 11 | Antibacterial, Antifungal, Antibiofilm | 18.75 ± 0.42 % Hemolysis at 150 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 35145500 | 2022 | RRLFRRILRWL{ct:Amid} | RW-BP-100 | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antifungal, Antibiofilm | 56.67 ± 6.33 % Hemolysis at 300 μg/mL | Sheep | Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues | NA | NA | ||
| 35145500 | 2022 | RRLF{d}RRILRWL{ct:Amid} | RW-BP100-4D* | Amidation | Free | Linear | Mix | None | 11 | Antibacterial, Antifungal, Antibiofilm | 48.55 ± 2.53 % Hemolysis at 300 μg/mL | Sheep | Rw-Bp-100 Analogue | NA | NA | ||
| 34506798 | 2022 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 1 % Hemolysis at 2 μM | Sheep | Venom Of The Spider Lycosa Singoriensis | 30 mM SDS and 50% TFE = α-Helical | Low hemolytic | ||
| 34506798 | 2022 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | <5 % Hemolysis at 16 μM | Sheep | Venom Of The Spider Lycosa Singoriensis | 30 mM SDS and 50% TFE = α-Helical | Low hemolytic | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 0.6 % Hemolysis at 5 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 0.8 % Hemolysis at 10 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 2.5 % Hemolysis at 20 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 8.7 % Hemolysis at 40 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 10.1 % Hemolysis at 60 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 14.8 % Hemolysis at 80 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 37.2 % Hemolysis at 100 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 36465844 | 2022 | GVKFAKRFWRFAKKAFKRFEK{nt:Amid} | HAZ | Free | Amidation | Linear | L | None | 21 | Antibacterial, Antibiofilm, Anticancer | 20 % Hemolysis at 120 μM | Human | Synthetic Hybride (Palustrin-1D And Hp(2–20)) Peptide | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid} | LL37-1 | Amidation | Free | Linear | L | None | 23 | Antibiofilm | ≤5 % Hemolysis at 1.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid} | DLL37-1 | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acid | 23 | Antibacterial, Antibiofilm | ≤5 % Hemolysis at 1.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid} | LL37-1 | Amidation | Free | Linear | L | None | 23 | Antibiofilm | ≤5 % Hemolysis at 2.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid} | DLL37-1 | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acid | 23 | Antibacterial, Antibiofilm | ≤5 % Hemolysis at 2.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid} | LL37-1 | Amidation | Free | Linear | L | None | 23 | Antibiofilm | ≤5 % Hemolysis at 5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid} | DLL37-1 | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acid | 23 | Antibacterial, Antibiofilm | ≤5 % Hemolysis at 5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid} | LL37-1 | Amidation | Free | Linear | L | None | 23 | Antibiofilm | ≤20 % Hemolysis at 10 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid} | DLL37-1 | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acid | 23 | Antibacterial, Antibiofilm | ≤20 % Hemolysis at 10 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36432731 | 2022 | TGLGKIGYLMKKLLSKAKV | LS-AMP-F1 | Free | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm | 17 % Hemolysis at 200 μM | Mouse | Spider Lycosa Sinensis | α-Helical | Low hemolytic | ||
| 36432731 | 2022 | AGMKNIIDAIKKKLGGKL | LS-AMP-E1 | Free | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | <37.5 % Hemolysis at 200 μM | Mouse | Spider Lycosa Sinensis | α-Helical | Low hemolytic | ||
| 36547631 | 2022 | RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC | defensin-like protein 1 (D-lp1) | Free | Free | Linear | L | None | 47 | Antifungal, Antibiofilm, Anti-virulence, Anti-Candida | 0.48 % Hemolysis at 0.19 mg/mL | Horse | Sulphur-Rich Defensin Present In Barley Endosperm | NA | Low hemolytic | ||
| 36547631 | 2022 | RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC | defensin-like protein 1 (D-lp1) | Free | Free | Linear | L | None | 47 | Antifungal, Antibiofilm, Anti-virulence, Anti-Candida | 1.74 % Hemolysis at 0.39 mg/mL | Horse | Sulphur-Rich Defensin Present In Barley Endosperm | NA | Low hemolytic | ||
| 36547631 | 2022 | RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC | defensin-like protein 1 (D-lp1) | Free | Free | Linear | L | None | 47 | Antifungal, Antibiofilm, Anti-virulence, Anti-Candida | 9.55 % Hemolysis at 0.78 mg/mL | Horse | Sulphur-Rich Defensin Present In Barley Endosperm | NA | Low hemolytic | ||
| 36547631 | 2022 | RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC | defensin-like protein 1 (D-lp1) | Free | Free | Linear | L | None | 47 | Antifungal, Antibiofilm, Anti-virulence, Anti-Candida | 14.72 % Hemolysis at 1.56 mg/mL | Horse | Sulphur-Rich Defensin Present In Barley Endosperm | NA | Low hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 5 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 10 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 20 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 40 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 60 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 80 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 100 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36668862 | 2023 | LLKKVLALLKKVL{nt:Amid} | Hp-MAP3 | Free | Amidation | Linear | L | None | 13 | Antibacterial, Antibiofilm, Antifungal, Anticancer | ~15 % Hemolysis at 10.8 μM | mouse | Temporin-Pta Analog | 50% TFE or SDS = α-Helix | NA | ||
| 36668862 | 2023 | LLKKVLALLKKVL{nt:Amid} | Hp-MAP3 | Free | Amidation | Linear | L | None | 13 | Antibacterial, Antibiofilm, Antifungal, Anticancer | 25 % Hemolysis at 21.6 μM | mouse | Temporin-Pta Analog | 50% TFE or SDS = α-Helix | NA | ||
| 36668862 | 2023 | LLKKVLALLKKVL{nt:Amid} | Hp-MAP3 | Free | Amidation | Linear | L | None | 13 | Antibacterial, Antibiofilm, Antifungal, Anticancer | ~85 % Hemolysis at 43.3 μM | mouse | Temporin-Pta Analog | 50% TFE or SDS = α-Helix | NA | ||
| 36903328 | 2023 | KRFKKFFKKLRKSVKKRVKKFFKKPKVIGVSIPF | Hydrostatin-AMP2 | Free | Free | Linear | L | None | 34 | Antibacterial, Antibiofilm | 4.6 % Hemolysis at 250 μg/mL | Human | Sea Snake Hydrophis Cyanocinctus | Water = Random coil, SDS = α-Helical | Low hemolytic | ||
| 37242633 | 2023 | VRLIVAVRIWRR{ct:Amid} | IDR1018 | Amidation | Free | Linear | L | None | 12 | Wound healing, Antibiofilm, Antibacterial | 20 % Hemolysis at 128 μg/mL | Human | Cationic Host Defense Peptides | NA | NA | ||
| 37242633 | 2023 | VRLIVAVRIWRR{nt:PEG6}{ct:Amid} | PEG6-IDR1018 | Amidation | PEG6 | Linear | L | None | 12 | Wound healing, Antibiofilm, Antibacterial | 0 % Hemolysis at 128 μg/mL | Human | Cationic Host Defense Peptides | NA | Non-hemolytic | ||
| 37242633 | 2023 | T({nnr:GlcNAc})VRLIVAVRIWRR{ct:Amid} | Glc-IDR1018 | Amidation | Free | Linear | L | GlcNAc = N-acetyl glucosamine | 13 | Wound healing, Antibiofilm, Antibacterial | 0 % Hemolysis at 128 μg/mL | Human | Cationic Host Defense Peptides | NA | Non-hemolytic | ||
| 36951612 | 2023 | AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5} | GLP6 | C6H12NO5 | C8H15O | Linear | L | None | 14 | Antibacterial, Antibiofilm | 5.15 % Hemolysis at 8 µM | mouse | Synthetic Glycosylated Lp6 Lipopeptide | SDS = 67.5% α-Helical, pure water =7 .38% α-Helical | NA | ||
| 36951612 | 2023 | AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5} | GLP6 | C6H12NO5 | C8H15O | Linear | L | None | 14 | Antibacterial, Antibiofilm | 15.6 % Hemolysis at 16 µM | mouse | Synthetic Glycosylated Lp6 Lipopeptide | SDS = 67.5% α-Helical, pure water =7 .38% α-Helical | NA | ||
| 36951612 | 2023 | AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5} | GLP6 | C6H12NO5 | C8H15O | Linear | L | None | 14 | Antibacterial, Antibiofilm | 60.67 % Hemolysis at 64 µM | mouse | Synthetic Glycosylated Lp6 Lipopeptide | SDS = 67.5% α-Helical, pure water =7 .38% α-Helical | NA | ||
| 37140456 | 2023 | VRVGPCDQVCSRTNPEKDECCRAHGHSGHSSCYGGRMNCYG | blapstin | Free | Free | Linear | L | None | 41 | Antibiofilm, Antifungal | 50 % Hemolysis at >112.5 µM | Human | Beetle Blaps Rhynchopetera | Random curl (34.80%), β-Turns (22.54%), β-Sheet (20.66%), α-Helix (5.22%) | NA | ||
| 37300579 | 2023 | HIDWKKLLDAAKQIL{ct:Amid} | MP1 | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm, Antifungal | 50 % Hemolysis at 221.4 µM | Human | Mastoparan Family | α-Helix | Low hemolytic | ||
| 37300579 | 2023 | HIDWKKLLDAAKKIL{ct:Amid} | MP1-Q12K | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm, Antifungal | 50 % Hemolysis at 187.4 µM | Human | Mp1 Analog | α-Helix | Low hemolytic | ||
| 37686259 | 2023 | RKYKEKKDKSQNKKKKRKCMIL | RK22 | Free | Free | Linear | L | None | 22 | Antibacterial, Antibiofilm | 0 % Hemolysis at 400 μg/mL | Mouse | Leech Hirudinaria Manillensis | NA | Non-hemolytic | ||
| 36508953 | 2023 | PFKLSLHL{ct:Amid} | Jelleine-I | Amidation | Free | Linear | L | None | 8 | Antibacterial, Antibiofilm, Anti-Listeria monocytogenes | 26.25 % Hemolysis at 1000 μg/mL | Rabbit | Honeybees Royal Jelly | NA | Low hemolytic | ||
| 36870201 | 2023 | FVQWFSKFLGRIL{ct:Amid} | Temporin L | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 50 % Hemolysis at 15 µM | Human | European Frog Rana Temporaria | PC/PG (3:1 w/w) = 70.1% Helical, PC/Chol (8:1 w/w) vesicles = 61.7% Helical | NA | ||
| 36870201 | 2023 | FVQWFSKF(βL)RIL{ct:Amid} | L9βl-TL | Amidation | Free | Linear | L | None | 12 | Antibacterial, Antibiofilm | 50 % Hemolysis at 33.3 µM | Human | Tl-Analogue | PC/PG (3:1 w/w) = 13.8% Helical, PC/Chol (8:1 w/w) vesicles = 7.2% Helical | NA | ||
| 37167720 | 2023 | RRWQWRP{d}PRWQWRR{ct:Amid} | Lf6-pP | Amidation | Free | Linear | L | p = D-Proline | 14 | Antibacterial, Antibiofilm, Anti-inflammatory | 10 % Hemolysis at >512 µM | Sheep | Synthetic Amps | Phosphate buffer and 50% TFE = typical TrpZip Hairpin, 30 mM SDS = α-Helical | Low hemolytic | ||
| 37167720 | 2023 | RRWQWRGGRWQWRR{ct:Amid} | Lf6-GG | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 10 % Hemolysis at >512 µM | Sheep | Synthetic Amps | Phosphate buffer and 50% TFE = typical TrpZip Hairpin, 30 mM SDS = α-Helical | Low hemolytic | ||
| 35216177 | 2022 | FVQWFSKFLGRIL | Temporin L | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼70 % Hemolysis at 100 µM | Human | Rana Temporaria (Red Frog) | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3 , DLeu9 ] TL | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial, Antibiofilm | ∼50 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVQWFSKFLGRIL | Temporin L | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼43 % Hemolysis at 50 µM | Human | Rana Temporaria (Red Frog) | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3 , DLeu9 ] TL | Amidation | Free | Linear | Mix | l = D-Leucine | 13 | Antibacterial, Antibiofilm | ∼25 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}GRIL{ct:Amid} | [Pro3,DLeu9] TL (TL1) | Amidation | Free | Linear | Mix | l=D-Leu | 13 | Antibacterial, Antibiofilm | 60 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}PRIL{ct:Amid} | [Pro3,DLeu9,Pro10] TL (TL2) | Amidation | Free | Linear | Mix | l=D-Leu | 14 | Antibacterial, Antibiofilm | 60 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}P{d}RIL{ct:Amid} | [Pro3,DLeu9,DPro10] TL (TL3) | Amidation | Free | Linear | Mix | l=D-Leu, p = D-Pro | 14 | Antibacterial, Antibiofilm | 20 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}{nnr:O}RIL{ct:Amid} | [Pro3,DLeu9,Hyp10] TL (TL4) | Amidation | Free | Linear | Mix | l=D-Leu, O = Hyp = hydroxyproline | 14 | Antibacterial, Antibiofilm | 80 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}{nnr:o}RIL{ct:Amid} | [Pro3,DLeu9,DHyp10] TL (TL5) | Amidation | Free | Linear | Mix | l=D-Leu, o = D-Hyp = hydroxyproline | 14 | Antibacterial, Antibiofilm | 20 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}{nnr:N=Nle}RIL{ct:Amid} | [Pro3,DLeu9,Nle10] TL (TL6) | Amidation | Free | Linear | Mix | l=D-Leu, N = Nle | 14 | Antibacterial, Antibiofilm | 60 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}{nnr:n=D-Nle}RIL{ct:Amid} | [Pro3,DLeu9,DNle10] TL (TL7) | Amidation | Free | Linear | Mix | l=D-Leu, n = D-Nle | 14 | Antibacterial, Antibiofilm | 40 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}KRIL{ct:Amid} | [Pro3,DLeu9,Lys10] TL (TL8) | Amidation | Free | Linear | Mix | l=D-Leu | 14 | Antibacterial, Antibiofilm | 80 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}K{d}RIL{ct:Amid} | [Pro3,DLeu9,DLys10] TL (TL9) | Amidation | Free | Linear | Mix | l=D-Leu, k = D-Lys | 14 | Antibacterial, Antibiofilm | 40 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}WRIL{ct:Amid} | [Pro3,DLeu9,Trp10] TL (TL10) | Amidation | Free | Linear | Mix | l=D-Leu | 14 | Antibacterial, Antibiofilm | 60 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFL{d}W{d}RIL{ct:Amid} | [Pro3,DLeu9,DTrp10] TL (TL11) | Amidation | Free | Linear | Mix | l=D-Leu, w = D-Trp | 14 | Antibacterial, Antibiofilm | 80 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35216177 | 2022 | FVPWFSKFl{nnr:Aic}RIL{ct:Amid} | [Pro3,DLeu9,Aic10] TL (TL12) | Amidation | Free | Linear | Mix | Aic = 2-aminoindane-2-carboxylic acid | 14 | Antibacterial, Antibiofilm | 100 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35323465 | 2022 | KWCI RVCRNGVCYRRCR | CT5 | Free | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | <2.5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35323465 | 2022 | RVC FRVCRNGVCYRRCW | CT6 | Free | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | <2.5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35323465 | 2022 | RVCIRVCYRGVCYRRCW | CT7 | Free | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 50 % Hemolysis at 128 µM | Human | Synthetic | NA | Low hemolytic | ||
| 35323465 | 2022 | KWCFRVCYRGICYRRCR | Tachyplesin-1 | Free | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | <5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 96 ± 2.1 % Hemolysis at 5 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 80.5 ± 2.3 % Hemolysis at 2.5 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 74.2 ± 2.2 % Hemolysis at 1.25 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 59.5 ± 1.8 % Hemolysis at 0.625 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 25 ± 1.2 % Hemolysis at 0.312 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 6 ± 0.8 % Hemolysis at 0.156 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.078 µg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.039 µg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 35282007 | 2022 | SMATPHAGAAALILSKHPTWTNAQVRDRLESTATYLGNSFYYGK | Natto peptide | Free | Free | Linear | L | None | 45 | Cytotoxicity, Antimicrobial, Antibiofilm | <1.8 % Hemolysis at 200 μg/ml | Rabbit | Soybeans | NA | Non-hemolytic | ||
| 35335979 | 2022 | FVDLKKIANILNSIF{ct:Amid} | Temporin-1CEh | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 50 % Hemolysis at 152.6 µM | Horse | Rana Chensinensis | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANILNSIF{ct:Amid} | Temporin-1CEh | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 92.3 % Hemolysis at 256 µM | Horse | Rana Chensinensis | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANIINSIF{ct:Amid} | Temporin-1CEa | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 50 % Hemolysis at 160 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANIL{ct:Amid} | T1CEh-t | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antibiofilm | <5 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANII{ct:Amid} | T1CEa-t | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antibiofilm | 0 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKFVDLKKIANIL{ct:Amid} | T1CEh-KK | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKFVPLKKIANIL{ct:Amid} | T1CEh-KKP | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼1 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKWVPLKKIANIL{ct:Amid} | T1CEh-KKPW | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | <10 % Hemolysis at 256 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKWVPWKKIANIL{ct:Amid} | T1CEh-KKPWW | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 6 % Hemolysis at 256 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKWVPWKKKWVPWKKIANIL{ct:Amid} | T1CEh-KKPWW2 | Amidation | Free | Branched | L | None | 20 | Antibacterial, Antibiofilm | 63 % Hemolysis at 256 µM | Horse | Synthetic | α-Helix | NA | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 3.1 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 6.2 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 12.5 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIRGALGRLF | GHaR6R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 200 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | >85 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | NA | ||
| 35538042 | 2022 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 50 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | NA | ||
| 35538042 | 2022 | FLQRIIRALGRLF | GHaR7R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | >100 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35538042 | 2022 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼1 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | <10 % Hemolysis at 50 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | <25 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIIGRLGRLF | GHaR8R | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | <50 % Hemolysis at 200 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 12.5 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 35538042 | 2022 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼10 % Hemolysis at 37.5 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35538042 | 2022 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 62.5 % Hemolysis at 100 µM | Human | Synthetic | α-Helix | NA | ||
| 35538042 | 2022 | FLQRIIGAWGRLF | GHaR9W | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | >100 % Hemolysis at 200 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSGIVGMLGKLF{ct:Amid} | SHa | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 50 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 2.812 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 2.812 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 2.812 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 1±0.62 % Hemolysis at 5.625 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 5.625 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 5.625 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 7±0.55 % Hemolysis at 11.25 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | <1 % Hemolysis at 11.25 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 1.8±0.9 % Hemolysis at 11.25 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 52.74 ± 5.94 % Hemolysis at 22.5 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 2.88 ± 1.24 % Hemolysis at 22.5 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 2 ± 0.94 % Hemolysis at 22.5 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 55.07 ± 5.23 % Hemolysis at 45 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 18.18 ± 7.65 % Hemolysis at 45 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 7.49 ± 1.20 % Hemolysis at 45 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 58.93 ± 6.02 % Hemolysis at 90 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 42.93 ± 4.75 % Hemolysis at 90 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 44.69 ± 3.73 % Hemolysis at 90 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 61.64 ± 13.83 % Hemolysis at 180 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 47.60 ± 7.88 % Hemolysis at 180 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 57.01 ± 8.50 % Hemolysis at 180 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVGMLA{d}KLF{ct:Amid} | [G10a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 64.71 ± 11.34 % Hemolysis at 360 µM | Human | Synthetic | α-Helix | NA | ||
| 35092568 | 2022 | FLSA{d}IVGMLGKLF{ct:Amid} | [G4a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 51.15 ± 10.41 % Hemolysis at 360 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35092568 | 2022 | FLSGIVA{d}MLGKLF{ct:Amid} | [G7a]-SHa | Amidation | Free | Linear | Mix | a = D-alanine | 13 | Antibacterial, Antibiofilm | 58.97 ± 5.51 % Hemolysis at 360 µM | Human | Synthetic | α-Helix | Low hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 1 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | <5 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | ∼1 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | <5 % Hemolysis at 1 mg/mL | Sheep | Synthetic | β-Hairpin | Low hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | <1 % Hemolysis at 0.5 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | <1 % Hemolysis at 0.1 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.05 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.01 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.005 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35563007 | 2022 | FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR | Zophobas atratus defensin | P80033.1 | Free | Free | Linear | L | None | 43 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Zophobas Atratus | NA | Non-hemolytic | ||
| 35563007 | 2022 | GGYCNSKSVCVCR{ct:Amid} | Z-d13 | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSVCVCR{ct:Amid} | Z-d14C | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCYCNSKSFCVCR{ct:Amid} | Z-d14CF | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSVCVCR{ct:Amid} | Z-d14CR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Sheet | Non-hemolytic | ||
| 35563007 | 2022 | RGCRCNSKSFCVCR{ct:Amid} | Z-d14CFR | Amidation | Free | Linear | L | None | 14 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.001 mg/mL | Sheep | Synthetic | β-Hairpin | Non-hemolytic | ||
| 35616397 | 2022 | GAIPKCCVGTSRNIPLSILMRVERYDVOHNHGACEIDAWLHANGRKYCADPRVKKVLGVAMQIRKAQLMREKLNSIMRR | omCK11 | Free | Free | Linear | L | None | 79 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Oncorhynchus Mykiss | α-Helix | NA | ||
| 35616397 | 2022 | AHPKVKRKLKRMQRKKDGKQKRH | omCCL28-like-23 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | ATPKMEQFLQKLMKRMARLKASAV | drCCL27b-24 | Free | Free | Linear | L | None | 24 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | AHPKWMEVRSRQRKKKHNKRRATY | IcCCL28-25 | Free | Free | Linear | L | None | 24 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | APLKMKAILEIVHRRMKQNKMKAAF | smCCL27b-25 | Free | Free | Linear | L | None | 25 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | VDQTVFKDIWWRMKQWKQRVKKRAAKYNV | trCCL28-29 | Free | Free | Linear | L | None | 29 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | AHPRIKKHLDLLMKKKRHLAMKIAAP | chCCL27a-26 | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35377553 | 2022 | FFGSVLKLIPKIL | temporin-PTa | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 13 % Hemolysis at 87 µM | Mus musculus | Hylarana Picturata | α-Helix | NA | ||
| 35377553 | 2022 | AAGKVLKLLKKLL | Hp-MAP1 | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | Hemolytic | Mus musculus | Synthetic; Temporin-Pta | α-Helix | NA | ||
| 35377553 | 2022 | AAKKVLKLLKKLL | Hp-MAP2 | Free | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | Hemolytic | Mus musculus | Synthetic; Temporin-Pta | α-Helix | NA | ||
| 35526666 | 2022 | FFSLIPSLVGGLISAFK{ct:Amid} | Stig (stigmurin) | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 0 % Hemolysis at 150–1.17 µM | Human | Tityus Stigmurus | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPKLVGKLISAFK{ct:Amid} | StigA8 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 11.5 % Hemolysis at 9.17 µM | Human | Synthetic; Analog Of Stigmurin | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPKLVGKLIKAFK{ct:Amid} | StigA18 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 14 % Hemolysis at 9.17 µM | Human | Synthetic; Analog Of Stigmurin | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPKLVGKLISAFK{ct:Amid} | StigA8 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 15 % Hemolysis at 150 µM | Human | Synthetic; Analog Of Stigmurin | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPKLVGKLIKAFK{ct:Amid} | StigA18 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 22 % Hemolysis at 150 µM | Human | Synthetic; Analog Of Stigmurin | α-Helix | Non-hemolytic | ||
| 35526666 | 2022 | FFSLIPSLVKKLIKAFK{ct:Amid} | StigA25 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 100 % Hemolysis at 150 µM | Human | Synthetic; Analog Of Stigmurin | NA | NA | ||
| 35526666 | 2022 | FFKLIPKLVKKLIKAFK{ct:Amid} | StigA31 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 80 % Hemolysis at 150 µM | Human | Synthetic; Analog Of Stigmurin | NA | NA | ||
| 35526666 | 2022 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 5 % Hemolysis at 160 µM | Human | T. Serrulatus Scorpion | NA | NA | ||
| 35526666 | 2022 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antibacterial, Antibiofilm | 86 % Hemolysis at 40 µM | Human | T. Serrulatus Scorpion | NA | NA | ||
| 35966656 | 2022 | KWKLFKKIHKVGQNIRKGIIKAGPAVAVVGQAAQIAK | PEW300 | Free | Free | Linear | L | None | 37 | Antibacterial, Antibiofilm | 0 % Hemolysis at 50 to 250 μg/ml | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 20451254 | 2010 | FLSLIPHIVSGVASIAKHF{ct:Amid} | Phylloseptin-1 (PSN-1) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Antiparasitic, Hemolytic, Antibiofilm | 6.7 % Hemolytic at 5µM | Horse | The Waxy Monkey Frog, Phyllomedusa Sauvagei, South America | Helix | NA | ||
| 30802593 | 2019 | FIVPSIFLLKKAFCIALKKC | Japonicin-2LF | Free | Free | Linear | L | None | 20 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm | >80 % Hemolytic at 64µM | Horse | Fujian Large-Headed Frog Skin Secretion, Limnonectes Fujianensis, China, Asia | Helix | NA | ||
| 37228702 | 2023 | FLPLLAGLAANFLPQIICKIARKC | Brevinin-1-AW | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance | 50 % Hemolytic at 23.96µM | Horse | Skin Secretion, The Wuyi Torrent Frog, Amolops Wuyiensis, China, Asia | Helix | NA | ||
| 37228702 | 2023 | FLPLLAGLAANFLPKIICKIARKC | B1AW-K | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance | 50 % Hemolytic at 10.6µM | Horse | Synthetic Peptide | Helix | NA | ||
| 38074470 | 2023 | FLGTVLKVAAKVLPAALCQIFKKC | Brevinin-1LTe | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 6.4µM | Human | Skin Secretion, The Broad-Folded Frog, Hylarana Latouchii | NA | NA | ||
| 38360076 | 2024 | KWIRRIIRDYKKFFIKFII | KWI-19 | Free | Free | Linear | L | None | 19 | Antifungal, Hemolytic, Antibiofilm | 50 % Hemolytic at 10µM | Human | Synthetic Peptide | Helix | NA | ||
| 38611812 | 2024 | FLPLLAGLAASFLPTIFCKISRKC{ct:C-terminus contains a Rana box: one disulfide bond.} | Brevinin-1BW | C-terminus contains a Rana box: one disulfide bond. | Free | Linear | L | None | 24 | Antibacterial, Anti-inflammatory, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 35.8µg/ml | Sheep | Skin, Pelophylax Nigromaculatus, East Asia | NA | NA | ||
| 36138742 | 2022 | FLKIIGKLLSGLL | VM-3K | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 11.2µM | Horse | Synthetic Peptide | Helix | NA | ||
| 36138742 | 2022 | FLGIIGKLLSGLL | VM-3G | Free | Free | Linear | L | None | 13 | Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 9.7µM | Horse | Synthetic Peptide | Helix | NA | ||
| 36138742 | 2022 | FLWIIGKLLSGLL | VM-3W | Free | Free | Linear | L | None | 13 | Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 9.7µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPHAISAVSALAKHL | Phylloseptin-TO2 | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 64µM | Horse | Skin Secretion, Super Tiger Leg Monkey Tree Frog, Phyllomedusa Tomopterna, Central America, South America | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAISAVSALAKHL | PSTO2 7K | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 32-64µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAISAVSALAKKL | PSTO2 18K | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 64µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAIKAVSALAKKL | PSTO2 SR (Phylloseptin-TO2 analog) | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 64µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAIKAVKALAKKL | PSTO2 SR2 (Phylloseptin-TO2 analog) | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39138237 | 2024 | FLPFLASLALKIL{ct:Amid} | Temporin-WY2 (Natural AMPs, Leu-rich, frog, amphibians, animals, XXA, UCLL1c) | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 32-64µM | Horse | Cutaneous Secretion, The Ranidae Frog, Amolops Wuyiensis, China, Asia | Helix | NA | ||
| 39138237 | 2024 | FLPKLLSALAKIL{ct:Amid} | QUB-1426 (Synthetic AMPs, Temporin-WY2 analog, Leu-rich, XXA, UCLL1c | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 16-32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39138237 | 2024 | KKKKKKFLPFLASLALKIL{ct:Amid} | 6K-WY2 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39138237 | 2024 | KKKKKKFLPKLLSALAKIL{ct:Amid} | 6K-1426 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 30734396 | 2019 | LLGMIPVAITAISALSKL{ct:Amid} | Medusin-TR1 (MDS-TR1) (Phylloseptin-4TR) (PLS-4TR) | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antifungal, Anti-inflammatory, Antibiofilm | 50 % Hemolytic at 65µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | Helical | NA |